<body> <document>  <type>   10-K   <sequence>    1    <filename>     NVE_2021_10K--Draft.htm     <description>      ANNUAL REPORT FOR THE YEAR ENDED MARCH 31, 2021      <text>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <a href="#TOC">         <b>          Table of Contents         </b>        </a>       </font>       <hr noshade="" size="3" style="margin-top: -5px; color: black;"/>       <hr noshade="" size="1" style="margin-top: -14px; color: black;"/>       <div align="center">        <b>         <font style="font-size: 10pt; font-family: Times New Roman">          UNITEDSTATES          <br/>          SECURITIES AND EXCHANGE COMMISSION          <br/>          Washington, D.C.  20549          <br/>         </font>        </b>        <table border="0" cellpadding="0" cellspacing="00" style="font-size:4pt;" width="80">         <tbody>          <tr>           <td style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 10pt 0pt 0pt;">           </td>          </tr>          <tr>           <td>           </td>          </tr>         </tbody>        </table>        <b>         <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">          FORM 10-K         </font>        </b>       </div>       <font style="font-size: 8pt; font-family: Times New Roman">        (Mark One)        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        [X]  ANNUALREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <div align="right">         For the fiscal year ended         <b>          March 31, 2021         </b>        </div>        [   ]       </font>       <font style="font-size: 10pt; font-family: Times New Roman letter-spacing: -.02em;">        TRANSITIONREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <div align="right">         For the transition period from _____________________to____________________        </div>        Commission file number        <b>         000-12196        </b>        <br/>        <div align="center">         <img alt="NVE Logo" height="26" src="logo-10k.gif" width="132"/>         <br/>         <b>          NVE CORPORATION         </b>         <br/>         (Exact name of registrant as specified in its charter)        </div>       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr align="center">          <td width="50%">           <b>            Minnesota           </b>          </td>          <td>           <b>            41-1424202           </b>          </td>         </tr>         <tr align="center">          <td>           State or other jurisdiction of incorporation or organization          </td>          <td>           (I.R.S. Employer Identification No.)          </td>         </tr>         <tr>          <td colspan="2" height="8">          </td>         </tr>         <tr align="center">          <td>           <b>            11409 Valley View Road, Eden Prairie, Minnesota           </b>          </td>          <td>           <b>            55344           </b>          </td>         </tr>         <tr align="center">          <td>           (Address of principal executive offices)          </td>          <td>           (Zip Code)          </td>         </tr>         <tr>          <td colspan="2" height="8">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        Registrant’stelephone number, including area code        <b>         (952) 829-9217        </b>        <font style="line-height: 5pt;">         <br/>         <br/>        </font>        Securities registered pursuant to Section 12(b) of the Act:       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr align="center">          <td width="33%">           <u>            Title of each class           </u>          </td>          <td width="33%">           <u>            Trading symbol(s)           </u>          </td>          <td>           <u>            Name of each exchange on which registered           </u>          </td>         </tr>         <tr align="center">          <td width="33%">           <b>            Common Stock, $0.01 par value           </b>          </td>          <td>           <b>            NVEC           </b>          </td>          <td>           <b>            The NASDAQ Stock Market, LLC           </b>          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <div align="center">         Securities registered pursuant to Section 12(g) of the Act:         <b>          None         </b>        </div>       </font>       <font style="font-size: 10pt; font-family: Times New Roman; line-height: 5pt;">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        Indicateby check mark if the registrant is a well-known seasoned issuer, as defined inRule 405 of the Securities Act.        <div align="right">         Yes [   ]  No [X]        </div>        Indicateby check mark if the registrant is not required to file reports pursuant to Section13 or Section 15(d) of the Act.        <div align="right">         Yes [   ]  No[X]        </div>        Indicateby check mark whether the registrant (1) has filed all reports required to befiled by Section 13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required tofile such reports), and (2) has been subject to such filing requirements for thepast 90 days.        <div align="right">         Yes [X]  No[   ]         <br/>        </div>        Indicateby check mark whether the registrant has submitted electronically every InteractiveData File required to be submitted and posted pursuant to Rule 405 of RegulationS-T (Section 232.405 of this chapter) during the preceding 12 months (or for suchshorter period that the registrant was required to submit such files).        <br/>        <div align="right">         Yes [X]  No [   ]        </div>        Indicate by check mark whether the registrant isa large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “largeaccelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the ExchangeAct.       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="3">          </td>          <td width="67%">           Large accelerated filer [   ]          </td>          <td align="right">           <div align="center">            Accelerated filer [   ]           </div>          </td>         </tr>         <tr>          <td rowspan="2" valign="top">           Non-accelerated filer [X]          </td>          <td align="right">           <div align="center">            Smaller reporting company [X]           </div>          </td>         </tr>         <tr>          <td align="right">           <div align="center">            Emerging growth company [   ]           </div>          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <font style="line-height: 5pt;">         <br/>        </font>        Ifan emerging growth company, indicate by check mark if the registrant has electednot to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section 13(a) of the ExchangeAct. [   ]        <font style="line-height: 5pt;">         <br/>         <br/>        </font>        Indicate bycheck mark whether the registrant has filed a report on and attestation to itsmanagement’s assessment of the effectiveness of its internal control overfinancial reporting under        <font style="white-space: nowrap;">         Section 404(b)        </font>        of the Sarbanes-Oxley Act        <font style="white-space: nowrap;">         (15 U.S.C. 7262(b))        </font>        by the registered public accounting firm that prepared or issued its audit report.   [   ]        <font style="line-height: 5pt;">         <br/>         <br/>        </font>        Indicate by check mark whether the registrantis a shell company (as defined in Rule 12b-2 of the Act).   Yes [   ]  No [X]        <font style="line-height: 5pt;">         <br/>         <br/>        </font>        The aggregate market value of the votingstock held by non-affiliates of the Registrant, based on the closing price onSeptember 30, 2020, the last business day of the Registrant’s most recentlycompleted second fiscal quarter, as reported on the NASDAQ Stock Market, was approximately$147  million.        <font style="line-height: 5pt;">         <br/>         <br/>        </font>        The number of shares of the registrant’sCommon Stock (par value $0.01) outstanding as of April 30, 2021 was 4,833,232.       </font>       <div align="center">        <table border="0" cellpadding="0" cellspacing="00" style="font-size:4pt;" width="80">         <tbody>          <tr>           <td style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt 10pt 0pt 0pt;">           </td>          </tr>          <tr>           <td>           </td>          </tr>         </tbody>        </table>        <font style="font-size: 10pt; font-family: Times New Roman">         <b>          DOCUMENTS INCORPORATED BY REFERENCE         </b>        </font>       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        Portionsof our Proxy Statement for our 2021 Annual Meeting of Shareholders are incorporatedby reference into Items 10, 11, 12, 13, and 14 of Part III hereof.        <br/>        <br/>       </font>       <div id="PN" style="page-break-after: always;">        <hr noshade="" size="1" style="margin-top: -5px; color: black;"/>        <hr noshade="" size="3" style="margin-top: -15px; color: black;"/>       </div>       <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">        <br/>        <br/>        <div align="center">         <a name="TOC">         </a>         <b>          NVE CORPORATION          <br/>          INDEX TO FORM 10-K         </b>        </div>       </font>       <font style="font-size: 10pt; font-family: Times New Roman;">        <br/>        <b>         <a href="#part1">          PART I         </a>        </b>        <div style="margin-left: 18pt;">         <a href="#item1">          Item 1. Business.         </a>        </div>        <div style="margin-left: 36pt;">         <a href="#strategy">          Our Strategy         </a>         <br/>         <a href="#prodsandmkts">          Our Products and Markets         </a>        </div>        <div style="margin-left: 36pt;">         <a href="#mfg">          Product Manufacturing         </a>         <br/>         <a href="#sales">          Sales and Product Distribution         </a>         <br/>         <a href="#newproducts">          New Product Status         </a>         <br/>         <a href="#competition">          Our Competition         </a>         <br/>         <a href="#suppliers">          Sources and Availability of Raw Materials         </a>         <br/>         <a href="#IP">          Intellectual Property         </a>         <br/>         <a href="#majorcustomers">          Dependence on Major Customers         </a>         <br/>         <a href="#government">          Compliance With Government Regulations         </a>         <br/>         <a href="#HR">          Human Capital Resources         </a>         <br/>         <a href="#availinfo">          Available Information         </a>        </div>        <div style="margin-left: 18pt;">         <a href="#item1a">          Item 1A. Risk Factors.         </a>         <br/>         <a href="#item1b">          Item 1B. Unresolved Staff Comments.         </a>         <br/>         <a href="#item2">          Item 2. Properties.         </a>         <br/>         <a href="#item3">          Item 3. Legal Proceedings.         </a>         <br/>         <a href="#item4">          Item 4. Mine Safety Disclosures.         </a>        </div>        <br/>        <b>         <a href="#partII">          PART II         </a>        </b>        <div style="margin-left: 18pt;">         <a href="#item5">          Item 5. Market for Registrant’sCommon Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.         </a>        </div>        <div style="margin-left: 36pt;">         <a href="#MarketInfo">          Market Information and Dividends         </a>         <br/>         <a href="#Shareholders">          Shareholders         </a>         <br/>         <a href="#Authorized">          Securities Authorized for Issuance Under Equity CompensationPlans         </a>         <br/>         <a href="#buyback">          Stock Repurchase Program         </a>         <br/>        </div>        <div style="margin-left: 18pt;">         <a href="#item7">          Item 7. Management’s Discussionand Analysis of Financial Condition and Results of Operations.         </a>         <br/>         <a href="#item8">          Item 8. Financial Statements and Supplementary Data.         </a>         <br/>         <a href="#item9A">          Item 9A. Controls and Procedures.         </a>         <br/>         <a href="#item9A">          Item 9B. Other Information.         </a>         <br/>        </div>        <br/>        <b>         <a href="#part3">          PART III         </a>        </b>        <div style="margin-left: 18pt;">         <a href="#item10">          Item 10. Directors, ExecutiveOfficers and Corporate Governance.         </a>         <br/>         <a href="#item11">          Item 11. Executive Compensation.         </a>         <br/>         <a href="#item12">          Item 12. Security Ownership of Certain Beneficial Owners andManagement and Related Stockholder Matters.         </a>         <br/>         <a href="#item13">          Item 13. Certain Relationships and Related Transactions, andDirector Independence.         </a>         <br/>         <a href="#item14">          Item 14. Principal Accounting Fees and Services.         </a>         <br/>        </div>        <br/>        <b>         <a href="#itemIV">          PART IV         </a>        </b>        <div style="margin-left: 18pt;">         <a href="#item15">          Item 15. Exhibits, FinancialStatement Schedules.         </a>        </div>        <br/>        <b>         <a href="#signatures">          SIGNATURES         </a>        </b>        <br/>        <br/>        <b>         <a href="#Report">          FINANCIAL STATEMENTS         </a>        </b>        <div style="margin-left: 18pt;">         <a href="#Report">          Reports of Independent RegisteredPublic Accounting Firm         </a>         <br/>         <a href="#BS">          Balance Sheets         </a>         <br/>         <a href="#income">          Statements of Income         </a>         <br/>         <a href="#CompIncome">          Statements of Comprehensive Income         </a>         <br/>         <a href="#SHE">          Statements of Shareholders’ Equity         </a>         <br/>         <a href="#CF">          Statements of Cash Flows         </a>         <br/>         <a href="#notes">          Notes to Financial Statements         </a>         <br/>        </div>        <br/>        <br/>       </font>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <u>           <a name="part1">            PARTI           </a>          </u>         </b>        </font>       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <b>         FORWARD-LOOKING STATEMENTS        </b>        <br/>        Some of the statements made in this Report or inthe documents incorporated by reference in this Report and in other materialsfiled or to be filed by us with the Securities and Exchange Commission (“SEC”)as well as information included in verbal or written statements made by us constituteforward-looking statements within the meaning of the Private Securities LitigationReform Act of 1995. These statements are subject to the safe harbor provisionsof the reform act. Forward-looking statements may be identified by the use ofthe terminology such as may, will, expect, anticipate, intend, believe, estimate,should, or continue, or the negatives of these terms or other variations of thesewords or comparable terminology. To the extent that this Report contains forward-lookingstatements regarding the financial condition, operating results, business prospectsor any other aspect of NVE, you should be aware that our actual financial condition,operating results and business performance may differ materially from that projectedor estimated by us in the forward-looking statements. We have attempted to identify,in context, some of the factors that we currently believe may cause actual futureexperience and results to differ from their current expectations. These differencesmay be caused by a variety of factors, including but not limited to risks relatedto our reliance on several large customers for a significant percentage of revenue,uncertainties related to the economic environments in the industries we serve,uncertainties related to future sales and revenues, risksrelated to the COVID-19 pandemic, risks and uncertainties related to futurestock repurchases and dividend payments, and other specific risks that may bealluded to in this Report or in the documents incorporated by reference in thisReport. For more information regarding our risks and uncertainties, see Item 1A“Risk Factors” of this Report.        <br/>        <br/>        <b>         <a name="item1">          ITEM 1. BUSINESS.         </a>         <br/>         In General        </b>        <br/>        NVE Corporation, referred to as NVE, we, us, orour, develops and sells devices that use spintronics, a nanotechnology that relieson electron spin rather than electron charge to acquire, store and transmit information.We manufacture high-performance spintronic products including sensors and couplersthat are used to acquire and transmit data.        <br/>        <br/>        <b>         NVE History and Background        </b>        <br/>        NVE is a Minnesota corporation headquartered ina suburb of Minneapolis. We were founded in 1989 by James M. Daughton, Ph.D.,a spintronics pioneer. Our common stock became publicly traded in 2000 througha reverse merger and became NASDAQ listed in 2003. Since our founding, we havebeen awarded more than $50 million in government research contracts. Thesecontracts have helped us develop products and build our intellectual propertyportfolio. We have adopted a March 31 fiscal year, so fiscal years referencedin this report end March 31.        <br/>        <br/>        <b>         Industry Background        </b>        <br/>        Much of the electronics industry is devoted to theacquisition, storage, and transmission of information. We have focused on threeapplications for our spintronic technology: magnetic sensors, couplers, and memories.Sensors acquire information, couplers transmit information, and memories storeinformation. In that sense, our technology can provide the eyes, nerves, and brainsof electronic systems.        <br/>        <br/>        Magnetic sensors can be used for a number of purposesincluding detecting the position or speed of robotics and mechanisms, or for communicatingwith implantable medical devices. We believe our spintronic sensors are smaller,more precise, and more reliable than competing devices.        <br/>        <br/>        Couplers are widely used in factory automation,providing reliable digital communication between electronic subsystems in factories.For example, couplers are used to send high-speed data between robots and centralcontrollers. As manufacturing automation expands, there is a need for higher speeddata and more channel density. Because of their unique properties, we believeour couplers transmit more data at higher speeds and over longer distances thanconventional devices.        <br/>        <br/>        Near-term potential MRAM applications include mission-criticalstorage such as military, industrial, and antitamper applications. Long term,MRAM could address the market for ubiquitous high-density memory.        <br/>        <br/>        <b>         Our Enabling Technology        </b>        <br/>        Our designs are generally based on either giantmagnetoresistance or tunneling magnetoresistance. These structures produce a largechange in electrical resistance depending on the electron spin orientation ina free layer.        <br/>        <br/>        In giant magnetoresistance (GMR) devices, resistancechanges due to conduction electrons scattering at interfaces within the devices.The GMR effect is only significant if the layer thicknesses are less than themean free path of conduction electrons, which is approximately five nanometers.Our critical GMR conductor layers may be less than two nanometers, or five atomiclayers, thick.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         3        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        The second type of spintronic structure we use isbased on tunneling magnetoresistance (TMR). Such devices are known as Spin-DependentTunnel (SDT) junctions or Magnetic Tunnel Junctions (MTJs). SDT junctions usetunnel barriers that are so thin that electrons can “tunnel” througha normally insulating material to cause a resistance change. SDT barrier thicknessescan be in the range of one to four nanometers (less than ten molecular layers).        <br/>        <br/>        In our products, the spintronic elements are connectedto integrated circuitry and encapsulated (“packaged”) in much the same wayas conventional integrated circuits.        <br/>        <br/>        <a name="strategy">        </a>        <b>         Our Strategy        </b>        <br/>        Our vision is to become the leading developer ofpractical spintronics technology and devices. Our spintronic technology provideseyes, nerves, and brains for electronic systems, breathing life and intelligenceinto inanimate objects. Our unique products support global trends of smart, low-powerend nodes for the “Internet of Things.” We plan to monetize our technologyby selling the products described below and licensing our MRAM technology. Togrow product sales, we plan to broaden our sensor and coupler product lines, andlonger term to target larger markets such as automotive electronics.        <br/>        <br/>        <a name="prodsandmkts">        </a>        <b>         Our Products and Markets        </b>        <br/>        <br/>        <a name="Sensors">        </a>        <b>         <i>          Sensor Products and Markets         </i>        </b>        <br/>        Our sensor products detect the strength or gradientof magnetic fields and are often used to determine position or speed. The GMRchanges its electrical resistance depending on the magnetic field. In our devices,GMR is combined with conventional foundry integrated circuitry and packaged inmuch the same way as conventional integrated circuits. We sell standard or catalogsensors, and custom sensors designed to meet customers’ exact requirements.Our sensors are quite small, very sensitive to magnetic fields, precise, and reliable.        <br/>        <br/>        <i>         Standard sensors        </i>        <br/>        Our standard, or catalog, sensors are generallyused to detect the presence of a magnetic or metallic material to determine positionor speed. We believe our spintronic sensors are smaller, more precise, more reliable,and lower power than competing devices. Our major market for standard sensorsis the Industrial Internet of Things (IIoT) for factory automation.        <br/>        <br/>        <i>         Custom and medical sensors        </i>        <br/>        Our primary custom products are sensors for medicaldevices, which are customized to our customers’ requirements and manufacturedunder stringent medical device quality standards. Most are used to replace electromechanicalmagnetic switches. We believe our sensors have important advantages in medicaldevices compared to electromechanical switches, including no moving parts forinherent reliability, and being smaller, more sensitive, and more precise. Oursensors can be customized using customer-specific integrated signal processingand design variations that can include the range and sensitivity to magnetic fields,electrical resistance, and multisensor elements configuration. Future custom sensortarget markets include consumer electronics, automotive electronics, and biosensors.        <br/>        <br/>        <a name="Couplers">        </a>        <b>         <i>          Coupler Products and Markets         </i>        </b>        <br/>        Our spintronic couplers combine a GMR sensor elementand an integrated microscopic coil. The coil creates a small magnetic field thatis picked up by the spintronic sensor, transmitting data almost instantly. Couplersare also known as “isolators” because they electrically isolate thecoupled systems. Our IsoLoop couplers are faster than the fastest optical couplers.Our major coupler market is currently the Industrial Internet of Things (IIoT)for factory automation. We are targeting the automotive market longer term.        <br/>        <br/>        <a name="MRAM">        </a>        <b>         <i>          MRAM Products and Markets         </i>        </b>        <br/>        MRAM uses spintronics to store data. It has beencalled the ideal or universal memory because of its potential to combine the speedof SRAM, the density of DRAM, and the nonvolatility of flash memory. Data is storedin the spin of the electrons in thin metal alloy films, and read with spin-dependenttunnel junctions. Unlike electrical charge, the spin of an electron is inherentlypermanent. We have invented several types of MRAM memory cells including inventionsrelated to advanced MRAM designs and MRAM for tamper prevention or detection.        <br/>        <br/>        Our strategy is to develop, manufacture, and selllow bit-density MRAM for applications such as tamper prevention and detection.For high bit-density MRAM, our strategy is to license our technology to companieswith large-scale memory manufacturing capabilities.        <br/>        <br/>        <a name="mfg">        </a>        <b>         Product Manufacturing        </b>        <br/>        The heart of our fabrication facility is a cleanroomarea with specialized equipment to deposit, pattern, etch, and process spintronicmaterials. Most of our products are fabricated in our facility using either rawsilicon wafers or foundry wafers. Foundry wafers contain conventional electronicsthat perform housekeeping functions such as voltage regulation and signal conditioningin our products.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         4        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        Each wafer may include thousands of devices. Webuild spintronics structures on wafers in our fabrication facility. We eithersaw wafers to be sold in die form, or send wafers to Asia for dicing and packaging.Other production operations include wafer-level inspection and testing. Packagedparts are returned to us to be tested, inventoried, and shipped.        <br/>        <br/>        <b>         <a name="sales">         </a>         Sales and Product Distribution        </b>        <br/>        We rely on distributors who stock our products andsell them in more than 75 countries. Distributors of our products includeAmerica II Electronics, Inc.,        <font style="white-space: nowrap;">         Angst+PfisterSensors and Power        </font>        , Avnet companies, and        <font style="white-space: nowrap;">         Digi-Key        </font>        Corporation. Our distributor agreements generally renew annually. In addition,we distribute versions of some of our products under private-brand partnershipswith large integrated device manufacturers. These private-brand partnerships broadenour distribution and enhance our sales support, technical support, and brand awareness.        <br/>        <br/>        <a name="newproducts">        </a>        <b>         New Product Status        </b>        <br/>        In the past year we began marketing a number ofnew and improved products, including:        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="4" width="1">          </td>          <td valign="top" width="1">           •          </td>          <td>           new smart sensors for the Internet of Things;          </td>         </tr>         <tr>          <td valign="top" width="1">           •          </td>          <td>           new TMR magnetic sensors and magnetic switches;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           data couplers with isolated power convertors; and          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           couplers with improved Common-Mode Transient Immunity for more efficientpower control.          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        Long-term product development programs in fiscal2021 included:        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="3" width="1">          </td>          <td valign="top" width="1">           •          </td>          <td>           new TMR sensors;          </td>         </tr>         <tr>          <td valign="top" width="1">           •          </td>          <td>           custom integrated circuits for smart sensors; and          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           power conversion integrated circuits.          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <a name="competition">        </a>        <b>         Our Competition         <br/>         <i>          Industrial Sensor Competition         </i>        </b>        <br/>        Several other companies either make or may havethe capability to make GMR or TMR sensors. Also, several competitors make solid-stateindustrial magnetic sensors including silicon Hall-effect sensors and anisotropicmagnetoresistive (AMR) sensors. We believe those types of sensors are not as sensitiveor power-efficient as our GMR or TMR sensors.        <br/>        <br/>        <b>         <i>          Medical Sensor Competition         </i>        </b>        <br/>        Our sensors for medical devices face competitionfrom electromechanical magnetic sensors and from other solid-state magnetic sensors.Electromechanical magnetic sensors such as reed and micro-electromechanical system(MEMS) switches have been in use for several decades. Because our sensors haveno moving parts, we believe they are inherently more reliable than electromechanicalmagnetic sensors. We also believe our sensors are smaller than the smallest electromechanicalmagnetic sensors, more precise in their magnetic switch points, and more sensitive.Compared to other solid-state sensors, our medical sensors may have advantagesin size, sensitivity to small magnetic fields, or electrical interface simplicity.        <br/>        <br/>        <b>         <i>          Coupler Competition         </i>        </b>        <br/>        Competing coupler technologies include optical couplers,inductive couplers (transformers), capacitive couplers, and radio-frequency modulationcouplers. Prominent optical coupler suppliers include Broadcom Limited, FairchildSemiconductor International, Lite-On Technology Corporation, Renesas ElectronicsCorporation, Toshiba Corporation, and Vishay Intertechnology.        <br/>        <br/>        Our strategy is to compete based on product featuresrather than to compete solely on price. IsoLoop couplers are smaller and thereforerequire less circuit board space per channel than most competing couplers. Ourother advantages over competing technologies may include less signal distortion,longer product life, and lower power consumption.        <br/>        <br/>        <b>         <i>          MRAM Competition         </i>        </b>        <br/>        A number of companies compete or may compete withus for MRAM research and development or service business, or may be attemptingto develop MRAM intellectual property for licensing to others. Emerging technologiesthat could compete with MRAM include graphene and carbon nanotubes, phase-changememory (PCM; also known as chalcogenide, 3D XPoint, or Ovonic memory), resistiveRAM (ReRAM or RRAM), conductive bridge RAM (CBRAM), memory resistors (“memristors”),and conductive metal oxide (CMOx) memory. MRAM may have advantages over thesetechnologies in either manufacturability, speed, bit density, data retention,or endurance.        <br/>        <br/>        <b>         <a name="suppliers">         </a>         Sources and Availability of Raw Materials        </b>        <br/>        Our principal sources of raw materials include suppliersof raw silicon and semiconductor foundry wafers that are incorporated into ourproducts, and suppliers of device packaging services. Our wafers sources are basedaround the world; most of our packaging services take place in Asia.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         5        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <p>        <font style="font-size: 10pt; font-family: Times New Roman">         <a href="#TOC">          <b>           Table  of Contents          </b>         </a>         <br/>         <br/>         <b>          <a name="IP">          </a>          Intellectual Property          <br/>          <i>           Patents          </i>         </b>         <br/>         As of March 31, 2021 we had more than 50  issued U.S. patents assigned to us. We also have a number of foreign patents,  a number of U.S. and foreign patents pending, and we have licensed patents from  others. There are no patents we regard as critical to our current business owned  by us or licensed to us that expire in the next 12 months.         <br/>         <br/>         <b>         </b>         We have patents on advanced MRAM designs  that we believe are important, including patents that relate to magnetothermal  MRAM, spin-momentum MRAM, and synthetic antiferromagnetic storage. Although  it is not critical to our current business, we have identified U.S. patent 6,744,086  titled “Current switched magnetoresistive memory cell” as particularly  important for successful high-density, high-performance MRAMs. The patent has  been reissued as RE 44,878 and expires May 15, 2022.         <br/>         <br/>         Much of our intellectual property has been developed  with U.S. Government support. Under federal legislation, companies normally  may retain the principal worldwide patent rights to any invention developed  with U.S. Government support.         <br/>         <br/>         <b>          <i>           Trademarks          </i>         </b>         <br/>         “NVE” and “IsoLoop” are our  registered trademarks. Other trademarks we claim include “GMR Switch”  and “GT Sensor.”         <br/>         <br/>         <a name="majorcustomers">         </a>         <b>          Dependence on Major Customers         </b>         <br/>         We rely on several large customers for a significant  percentage of our revenue, including Abbott        </font>        <font style="font-size: 10pt; font-family: Times New Roman">         Laboratories,  Sonova AG, certain other medical device manufacturers, and certain distributors.  The loss of one or more of these customers could have a material adverse effect  on us.         <br/>         <br/>         <a name="government">         </a>         <b>          Government Regulations         </b>         <br/>         We are subject to government regulations including,  but not limited to, regulations related to environment, tax matters, securities,  conflict minerals, ethics and foreign corrupt practices, import and export controls,  product safety and liability, workplace health and safety, labor and employment,  and data privacy. We incur and expect to continue to incur costs and expenses  to comply with these regulations and may incur penalties for any failure to  do so.         <br/>         <br/>         Additionally, certain contracts required us maintain  facilities and personnel security clearances to protect classified information.  Such clearances are subject Government audits and investigations, and any deficiencies  or illegal activities identified during the audits or investigations could result  in the forfeiture or suspension of payments and civil or criminal penalties.         <b>          <br/>          <br/>          Environmental Matters         </b>         <br/>         We are subject to environmental laws and regulations  particularly state and local laws and regulations relating to industrial waste  and emissions. Compliance with these laws and regulations has not had a material  impact on our capital expenditures, earnings, or competitive position to date.  Existing and future environmental laws and regulations could result in expenses  related to emission abatement or remediation, but we are currently unable to  estimate such expenses.         <br/>         <br/>         <a name="HR">         </a>         <b>          Human Capital Resources         </b>         <br/>         We had 44 employees as of March 31, 2021,  all of whom were full-time.         <br/>         <br/>         We have policies to prevent discrimination based  on gender, race, disability, ethnicity, nationality, religion, sexual orientation,  gender identity, or gender expression. We take affirmative action to ensure  that applicants are employed, and that employees are treated during employment,  without regard to their race, color, religion, sex, or national origin. We also  take affirmative action to employ and advance veterans in employment.         <br/>         <br/>         We offer employees free health risk assessments,  wellness programs, and financial incentives for healthy biometrics.         <br/>         <br/>         None of our employees are represented by a labor  union or are subject to a collective bargaining agreement, and we believe we  maintain good relations with our employees.         <br/>         <br/>         <a name="availinfo">         </a>         <b>          Available Information         </b>         <br/>         All reports we file with the SEC, including our  annual reports on         <font style="white-space: nowrap;">          Form 10-K         </font>         , quarterly  reports on         <font style="white-space: nowrap;">          Form 10-Q         </font>         , current reports  on         <font style="white-space: nowrap;">          Form 8-K         </font>         , and proxy statements  and additional proxy materials on Schedule 14A, as well as any amendments  to those reports and schedules, are accessible at no cost through the “Investors”  section of our Website (www.nve.com). These filings are also accessible through  the SEC’s Website (www.sec.gov).         <br/>         <br/>        </font>       </p>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         6        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <a name="item1a">        </a>        <b>         ITEM 1A. RISK FACTORS.        </b>        <br/>        We caution readers that the following importantfactors, among others, could affect our financial condition, operating results,business prospects or any other aspect of NVE, and could cause our actual resultsto differ materially from that projected or estimated by us in the forward-lookingstatements made by us or on our behalf. Although we have attempted to list belowthe important factors that do or may affect our financial condition, operatingresults, business prospects, or any other aspect of NVE, other factors may inthe future prove to be more important. New factors emerge from time to time andit is not possible for us to predict all of such factors. Similarly, we cannotnecessarily assess or quantify the impact of each such factor on the businessor the extent to which any factor, or combination of factors, may cause actualresults to differ materially from those contained in forward-looking statements.        <i>         <br/>        </i>        <br/>        <b>         Risks Related to our Business         <br/>         <i>          We may lose revenue if any of our large customers cancel, postpone, or reducetheir purchases.         </i>        </b>        <br/>        We rely on several large customers for a significantpercentage of our revenue. These large customers include Abbott Laboratories,Sonova AG, certain other medical device manufacturers, and certain distributors.Although we have agreements with certain large customers, these agreements donot obligate customers to purchase from us and may not prevent price reductions.Furthermore, orders from our large customers can generally be reduced, postponed,or canceled, and some orders were delayed or canceled due to the effects of theCOVID-19 pandemic. Any decreases in purchases,or the loss of any of our large customers, could have a significant impact onour revenue and our profitability.        <br/>        <br/>        <b>         <i>          We risk losing business to our competitors.         </i>        </b>        <br/>        We have a number of competitors and potential competitors,many of whom have significantly greater financial, technical, and marketing resourcesthan us. We believe that our competition is increasing as the technology and marketsmature. This has meant more competitors and more severe pricing pressure. In addition,our competitors may be narrowing or eliminating our performance advantages. Weexpect these trends to continue, and we may lose business to competitors or itmay be necessary to significantly reduce our prices in order to acquire or retainbusiness. These factors could cause a material adverse impact on our financialcondition, revenue, gross profit margins, or income.        <br/>        <br/>        <i>         <b>          Failure to meet stringent customer requirements could result in the lossof key customers and reduce our sales.         </b>        </i>        <br/>        Some of our customers, including certain medicaldevice manufacturers, have stringent technical and quality requirements that requireour products to meet certain test and qualification criteria or to adopt and complywith specific quality standards. Certain customers also periodically audit ourperformance. Failure to meet technical or quality requirements or a negative customeraudit could result in the loss of current sales revenue, customers, and futuresales.        <br/>        <br/>        <b>         <i>          We may lose revenue if we are unable to renew customer agreements.         </i>        </b>        <br/>        We have agreements with certain customers, includinga Supplier Partnering Agreement, as amended, with Abbott Laboratories, which expiresNovember 30, 2021, and Supply Agreement, as amended, with Sonova AG,which expires March 31, 2025. We cannot predict if these agreements willbe renewed, or if renewed, under what terms. Although it is possible we couldcontinue to sell products to these customers without formal agreements, an inabilityto agree on mutually acceptable terms or the loss of these customers could havea significant adverse impact on our revenue and our profitability.        <br/>        <br/>        <i>         <b>          Changes in tax law, in our tax rates or in exposure to additional incometax liabilities may materially and adversely affect our financial condition, resultsof operations, and cash flows.         </b>        </i>        <br/>        Changes in law and policy relating to taxesmay materially and adversely affect our financial condition, results of operationsand cash flows. For example, the 2017 Federal Tax Reform Act significantly decreasedour Federal income tax rate. The current administration and Congress could makechanges to existing tax law such as an increase in the corporate tax rate. Changesto existing Federal or state tax laws could adversely affect our financial conditionand results of operations.        <br/>        <br/>        <b>         <i>          We will lose revenue if government contract funding is reduced, delayed,or eliminated.         </i>        </b>        <br/>        A decrease in U.S. Government funded research ordisqualification as a vendor to the U.S. Government for any reason could hamperfuture research and development activity and decrease related revenue. In additionto direct Government funding, certain of our non-Government customers and prospectivecustomers depend on Government support to fund their contracts with us. Our directand indirect Government funding depends on adequate continued funding of the agenciesand their programs. Such funding is subject to the availability of Congressionalappropriations and that, as a result, long-term government contracts are partiallyfunded initially with additional funds committed only as Congress makes furtherappropriations. Certain contracts require us to maintain facilities and personnelsecurity clearances to protect classified information. Such clearances are subjectGovernment audits and investigations, and any deficiencies or illegal activitiesidentified during the audits or investigations could result in the forfeitureor suspension of payments and civil or criminal penalties. Furthermore, some ofour Government funding has been through Small Business Innovation Research (SBIR)or Small Business Technology Transfer Research (STTR) contracts. SBIR and STTRbudgets, eligibility, or funding limits may be changed by legislation or by agenciessuch as the Department of Defense.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         7        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <b>         <i>          If we were barred for any reason from U.S. government contracts there couldbe a significant adverse impact on our revenue and our ability to make researchand development progress.         </i>        </b>        <br/>        If we were to be charged with violation of certainlaws or if the U.S. Government were to determine that we are not a “presentlyresponsible contractor,” we could be temporarily suspended or, in the eventof a violation, barred for up to three years from receiving new U.S. Governmentcontracts or government-approved subcontracts. Additionally, we are subject toroutine government audits and may be subject to investigations, and any deficienciesor illegal activities identified during the audits or investigations may resultin the forfeiture or suspension of payments and civil or criminal penalties. Beingbarred for any reason from U.S. Government contracts could have a material adverseeffect on our revenue, profits, and research and development efforts.        <b>         <br/>        </b>        <br/>        <i>         <b>          Some of our products are incorporated into medical devices, which couldexpose us to a risk of product liability claims and such claims could seriouslyharm our business and financial condition.         </b>        </i>        <br/>        Certain of our products are used in medical devices,including devices that help sustain human life. We are also marketing our technologyto other manufacturers of cardiac pacemakers and ICDs. Although we have indemnificationagreements with certain customers including provisions designed to limit our exposureto product liability claims, there can be no assurance that we will not be subjectto losses, claims, damages, liabilities, or expenses resulting from bodily injuryor property damage arising from the incorporation of our products in devices soldby our customers. Our indemnifying customers may not have the financial resourcesto cover all liability. Existing or future laws or unfavorable judicial decisionscould limit or invalidate the provisions of our indemnification agreements, orthe agreements may not be enforceable in all instances. A successful product liabilityclaim could require us to pay, or contribute to payment of, substantial damageawards, which would have a significant negative effect on our business and financialcondition.        <br/>        <br/>        <b>         <i>          We may lose revenue if we are unable to maintain important certifications.         </i>        </b>        <br/>        Our quality management system is certified to theISO 9001 standard, and we have received a letter of conformance for the InternationalAutomotive Task Force (IATF) 16949 automotive sector-specific standard. Ourproducts are also subject to independent certification and listings includingby the VDE Institute and UL LLC. These certifications are subject toa number of rigorous conditions. Failure to achieve or maintain any of these certificationsor listings could cause us to be disqualified by one or more of our customers,and could have a material adverse impact on our business and revenue.        <br/>        <br/>        <b>         <i>          Federal legislation may not protect us against liability for the use ofour products in medical devices and a successful liability claim could seriouslyharm our business and financial condition.         </i>        </b>        <br/>        Although the Biomaterials Access Assurance Act of1998 may provide us some protection against potential liability claims, that Actincludes significant exceptions to supplier immunity provisions, including limitationsrelating to negligence or willful misconduct. A successful product liability claimcould require us to pay, or contribute to payment of, substantial damage awards,which would have a significant negative effect on our business and financial condition.Any product liability claim against us, with or without merit, could result incostly litigation, divert the time, attention, and resources of our managementand have a material adverse impact on our business.        <br/>        <br/>        <i>         <b>          The malfunction of our products in medical devices could lead to the needto recall devices incorporating our products from the market, which may be harmfulto our reputation and cause a significant loss of revenue.         </b>        </i>        <br/>        The malfunction of our products that are incorporatedin medical devices could lead to the recall of existing medical devices incorporatingour products. Such a recall could be harmful to our reputation for product safetyand efficacy. Even if assertions that our products caused or contributed to devicefailure do not lead to product liability or contract claims, such assertions couldharm our reputation and customer relationships. Any damage to our reputation and/orthe reputation of our products, or the reputation of our customers or their productscould limit the market for our and our customers’ products and harm our resultsof operations.        <br/>        <br/>        <b>         <i>          We may lose business and revenue if our critical production equipment fails.         </i>        </b>        <br/>        Our production process relies on certain criticalpieces of equipment for defining, depositing, and modifying the magnetic propertiesof thin films. Some of this equipment was designed or customized by us, and somemay no longer be in production. While we have an in-house maintenance staff, maintenanceagreements for certain equipment, some critical spare parts, and back-ups forsome of the equipment, we cannot be sure we could repair or replace critical manufacturingequipment were it to fail.        <br/>        <b>         <i>          <br/>          The loss of supply from any of our key single-source wafer suppliers could substantiallyimpact our ability to produce and deliver products and seriously harm our businessand financial condition.         </i>        </b>        <br/>        Our critical suppliers include suppliers of certainraw silicon and semiconductor foundry wafers that are incorporated in our products.We maintain inventory of some critical wafers, but we have not identified or qualifiedalternate suppliers for many of the wafers now being obtained from single sources.In the past fiscal year there have been industry-wide semiconductorwafer shortages and leadtimes have increased for certain of our foundry wafers.Wafer supply interruptions for any reason, including acts of God such as floods,typhoons, cyclones, earthquakes, or pandemics could seriously jeopardize our abilityto provide products that are critical to our business and operations, and maycause us to lose revenue.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         8        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <i>         <b>          The loss of supply of any critical chemicals or supplies could impact ourability to produce and deliver products and cause loss of revenue.         </b>        </i>        <br/>        There are a number of critical chemicals and suppliesthat we require to make products. These include certain gases, photoresists, polymers,metals, and specialized alloys. We maintain inventory of critical chemicals andmaterials, but in many cases we are dependent on single sources, and some of thematerials could be subject to shortages or be discontinued by their suppliersat any time. Supply interruptions or shortages for any reason could seriouslyjeopardize our ability to provide products that are critical to our business andoperations and may cause us to lose revenue.        <br/>        <br/>        <i>         <b>          The loss of supply from any of our packaging vendors could impact our abilityto produce and deliver products and cause loss of revenue.         </b>        </i>        <br/>        We are dependent on our packaging vendors. Becauseof the unique materials our products use, the complexity of some of our products,unique magnetic requirements, and high isolation voltage specifications, manyof our products are more challenging to package than conventional integrated circuits.Some of our products use processes or tooling unique to a particular packagingvendor, and it might be expensive, time-consuming, or impractical to convert toanother vendor in the event of a supply interruption due to vendors’ businessdecisions, business condition, or acts of God, including floods, typhoons, earthquakes,or pandemics. Leadtimes for packaging services have increased during the COVID-19pandemic and there have been shortages of raw materials and equipment our packagingvendors need for their process. One of our packaging vendors in India was forcedto suspend its factory operations from late March 2020 until mid-May 2020 andwas permitted only limited operation from mid-May through August 2020 pursuantto COVID-19 government orders, and is still not fully operational. Restrictionson our packaging vendors could be reimposed in the future. Additionally, certainof our packaging vendors are in flood-susceptible areas. Flooding risks to suchvendors may increase in the future due to possible higher ocean levels, extremeweather, and other potential effects of climate change. We have alternate vendorsor potential alternate vendors for the majority of our products, but it can beexpensive, time-consuming, and technically challenging to convert to alternatevendors. Furthermore, we may not be able to recover work in process or finishedgoods at a packaging vendor in the event of a disruption. Any supply interruptionsor loss of inventory could seriously jeopardize our ability to provide productsthat are critical to our business and operations and may cause us to lose revenue.        <br/>        <br/>        <b>         <i>          We are subject to risks inherent in doing business in foreign countriesthat could impair our results of operations.         </i>        </b>        <br/>        Foreign sales are a significant portion of our revenueand we rely on suppliers in China, India, Taiwan, Thailand, and other foreigncountries. Risks relating to operating in foreign markets that could impair ourresults of operations include economic and political instability; acts of God,including floods, typhoons, cyclones and earthquakes; public health crises including,but not limited to, the COVID-19 pandemic; difficulties in enforcement of contractualobligations and intellectual property rights; changes in regulatory requirements,tariffs, customs, duties, and other trade barriers; transportation delays; andother uncertainties relating to the administration of, or changes in, or new interpretationof, the laws, regulations, and policies of jurisdictions where we do business.        <br/>        <br/>        <i>         <b>          Public health crises could have an adverse effect on our operations andfinancial results.         </b>        </i>        <br/>        Public health crises could adversely affect ourongoing business operations. In particular, the COVID-19 pandemic has impactedglobal economic activity, caused many of our important customers to delay or cancelorders, and disrupted our supply chains. Any customer or supplier disruptionscould affect our ability to operate. These and other impacts of COVID-19 pandemicor other public health crises could have a material adverse effect on our resultsof operations or our financial condition.        <br/>        <br/>        <i>         <b>          We may not be able to enforce our intellectual property rights.         </b>        </i>        <br/>        We protect our proprietary technology and intellectualproperty by seeking patents, trademarks, and copyrights, and by maintaining tradesecrets through entering into confidentiality agreements with employees, suppliers,customers, and prospective customers depending on the circumstances. We hold patentsor are the licensee of others owning patented technology covering certain aspectsof our products and technology. These patent rights may be challenged, renderedunenforceable, invalidated, or circumvented. Additionally, rights granted underthe patents or under licensing agreements may not provide a competitive advantageto us. Efforts to enforce patent rights can involve substantial expense and maynot be successful. Furthermore, others may independently develop similar, superior,or parallel technologies to any technology developed by us, or our technologymay prove to infringe on patents or rights owned by others. Thus the patents heldby or licensed to us may not afford us any meaningful competitive advantage. Also,our confidentiality agreements may not provide meaningful protection of our proprietaryinformation. Our inability to maintain our proprietary rights could have a materialadverse effect on our business, financial condition, and results of operations.        <br/>        <br/>        <i>         <b>          Our business success may be adversely affected if we are unable to attractand retain highly qualified employees.         </b>        </i>        <br/>        We have employment agreements with certain employees,including our Chief Executive Officer and Chief Financial Officer, but those agreementsdo not prevent employees from leaving the company. Competition for highly qualifiedmanagement and technical personnel can be intense and we may not be able to attractand retain the personnel necessary for the development and operation of our business.The loss of the services of key personnel could have a material adverse effecton our business, financial condition, and results of operations.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         9        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <i>         <b>          Our businesscould be negatively impacted by cyber security events or information technologydisruptions.         </b>        </i>        <br/>        We face various cyber security threats, includingthreats to our information technology infrastructure and attempts to gain accessto our proprietary or classified information, and denial-of-service attacks. Additionally,there is a risk of disruptions due to failures of our information technology infrastructureor service provider outages. We maintain policies and procedures for the mitigationof information technology risks, and we maintain data backups, backup hardware,and some redundant systems. We have experienced cyber security events and disruptionssuch as viruses, ransomware, hacker attacks, and limited server, Website, ande-mail outages. Although these events did not materially impact our business,future events could disrupt our operations, harm our reputation, expose us toliability, compromise our eligibility for research and development contracts involvingsensitive or classified information, or have other effects including unpredictableeffects.        <br/>        <br/>        <b>         <i>          We could incur losses on our marketable securities.         </i>        </b>        <br/>        As of March 31, 2021, we held $54,717,626 inshort-term and long-term marketable securities, representing approximately 75%of our total assets. Conditions and circumstances beyond our control or abilityto anticipate, including the effects of the COVID-19 pandemic, can cause downgradesand increased default risk, and such downgradesor increases in default risk are possible at any time. Additionally, the assignmentof a high credit rating does not preclude the risk of default on any marketablesecurity. Defaults, default risks, or changes in market conditions could causeus to incur losses on our marketable securities, which could have a material adverseimpact on our financial condition, income, or cash flows, and our ability to paydividends.        <br/>        <br/>        <b>         Risks Related to our Industry         <br/>         <i>          We face an uncertain economic environment in the industries we serve, whichcould adversely affect our business.         </i>        </b>        <br/>        We sell our products into the semiconductor market,which is highly cyclical. We cannot predict the timing, strength, or durationof any economic slowdown or subsequent recovery, worldwide or in the industrieswe serve. The economic environment could have a material adverse impact on ourbusiness and revenue.        <br/>        <br/>        <i>         <b>          Our business and our reliance on intellectual property exposes us to litigationrisks.         </b>        </i>        <br/>        If patent infringement claims or actions are assertedagainst us, we may be required to obtain a license or cross-license, modify ourexisting technology or design a new noninfringing technology. Such licenses ordesign modifications can be costly or could increase the cost of our products.In addition, we may decide to settle a claim or action against us, which settlementcould be costly. We may also be liable for any past infringement, and we may berequired to indemnify our customers against expenses relating to possible infringement.If there is an adverse ruling against us in an infringement lawsuit, an injunctioncould be issued barring production or sale of any infringing product. It couldalso result in a damage award equal to a reasonable royalty or lost profits or,if there is a finding of willful infringement, treble damages. Any of these resultswould increase our costs or harm our operating results.        <br/>        <br/>        <b>         Risks Related to our Stock         <br/>         <i>          Any decisions to reduce or discontinue paying cash dividends to our shareholderscould cause the market price of our common stock to decline.         </i>        </b>        <br/>        Future dividends will be subject to Board approvaland will take into account factors including our results of operations,cash and marketable security balances, the timing ofsecurities maturations, estimates of future cash requirements, fixed asset requirements,the impacts of the COVID-19 pandemic, and other factors our Board may deem relevant.Because they are generally more than our current cash flow from operations, recentand declared dividend amounts may be unsustainable. Any reduction or discontinuanceby us of cash dividends could cause the market price of our common stock to decline.        <br/>        <br/>        <b>         <i>          The price of our common stock may be adversely affected by significant pricefluctuations due to a number of factors, many of which are beyond our control.         </i>        </b>        <br/>        From time to time our stock price has decreasedsharply, and could decline in the future. The market price of our common stockmay be significantly affected by many factors, some of which are beyond our control,including:        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="12" width="2">          </td>          <td valign="top" width="2">           •          </td>          <td>           the announcement of new products, product enhancements, or contracts by usor our competitors;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           delays in our introduction of new products or technologies or market acceptanceof these products or technologies;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           loss of customers, decreases in customers’ purchases, or decreases incustomers’ purchase prices;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           changes in demand for our customers’ products;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           quarterly variations in our financial results, revenue, or revenue growthrates;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           speculation in the press or analyst community about our business, potentialrevenue, or potential earnings;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           general economic conditions or market conditions specific to industries weor our customers serve or may serve;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           legal proceedings involving us, including intellectual property litigationor class action litigation;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           changes in Federal corporate income tax rates or changes in other tax provisions;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           changes in tariffs, customs, duties, or other trade barriers in foreign jurisdictionswhere we purchase raw materials or sell our products;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           the impact or perceived impact of the COVID-19 pandemic on general economic conditions, our industry, or our revenues or net income;          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           our stock repurchase and dividend policies and decisions.          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <div align="center">         10        </div>       </font>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <b>         <a name="item1b">         </a>         ITEM 1B. UNRESOLVED STAFF COMMENTS.        </b>        <br/>        None.        <br/>        <br/>        <b>         <a name="item2">          ITEM 2. PROPERTIES.         </a>        </b>        <br/>        Our principal executive offices and manufacturingfacility are located at 11409 Valley View Road, Eden Prairie, Minnesota, 55344,and leased under an agreement expiring March 31, 2026. The space consistsof 21,362 square feet of offices, laboratories, and production areas. The facilityis currently being utilized at less than maximum capacity to allow for growth,and we believe the facility is adequate to meet our current requirements. We holdno investments in real estate.        <br/>        <br/>        <b>         <a name="item3">          ITEM 3. LEGAL PROCEEDINGS.         </a>        </b>        <br/>        In the ordinary course of business we may becomeinvolved in litigation. At this time we are not aware of any material pendingor threatened legal proceedings or other proceedings contemplated by governmentalauthorities that we expect would have a material adverse impact on our futureresults of operation and financial condition.        <br/>        <br/>        <b>         <a name="item4">         </a>         ITEM 4. MINE SAFETY DISCLOSURES.        </b>        <br/>        Not applicable.        <br/>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <u>           <a name="partII">            PARTII           </a>          </u>         </b>        </font>       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <b>         <a name="item5">          ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATEDSTOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES.         </a>        </b>        <br/>        <a name="MarketInfo">        </a>        <b>         Market Information and Dividends        </b>        <br/>        Our Common Stock trades on the Capital Market tierof the NASDAQ Stock Market under the symbol NVEC.        <br/>        <br/>        Dividends have been funded from net cash providedby operating activities and proceeds from maturities of marketable securities.Our dividend policy is subject to change at any time, and future dividends willbe subject to Board approval and subject to the company’s results of operations,cash and marketable security balances, our forecasts of future cash requirements,and other factors our Board may deem relevant.        <br/>        <br/>        <a name="Shareholders">        </a>        <b>         Shareholders        </b>        <br/>        We have approximately 61 shareholders of recordas of April 16, 2021. There are also several thousand beneficial holdersof our common stock in “street name,” whose shares of record are held bybanks, brokers, and other financial institutions.        <br/>        <br/>        <a name="Authorized">        </a>        <b>         Securities Authorized for Issuance Under Equity CompensationPlans        </b>        <br/>        Information regarding our securities authorizedfor issuance under equity compensation plans will be included in the section “EquityCompensation Plan Information” of our Proxy Statement for our 2021 AnnualMeeting of Shareholders, and is incorporated by reference into Item 12 ofthis Report.        <br/>        <br/>        <a name="buyback">        </a>        <b>         Stock Repurchase Program        </b>        <br/>        On January 21, 2009 we announced that our Boardof Directors authorized the repurchase of up to $2,500,000 of our Common Stockfrom time to time in open market, block, or privately negotiated transactions.The timing and extent of any repurchases depends on market conditions, the tradingprice of the company’s stock, and other factors, and subject to the restrictionsrelating to volume, price, and timing under applicable law. On August 27,2015, we announced that our Board of Directors authorized up to $5,000,000 ofadditional repurchases. Our repurchase program does not have an expiration dateand does not obligate us to purchase any shares. The Program may be modified ordiscontinued at any time without notice. We intend to finance any stock repurchaseswith cash provided by operating activities or maturating marketable securities.We repurchased 1,806 shares of our Common Stock in fiscal 2021 and 12,972 sharesin fiscal 2020. The remaining authorization was $3,762,040 as ofMarch 31, 2021. Common Stock repurchases during each quarter offiscal 2021, all of which were made as part of our publicly announced program,were as follows:        <br/>        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman;" width="100%">        <tbody>         <tr>          <td colspan="7" valign="bottom">          </td>          <td align="center" valign="bottom">           <b>            Total number of           </b>          </td>          <td rowspan="5">          </td>          <td align="center" colspan="2">           <b>            Max. approximate           </b>          </td>         </tr>         <tr>          <td rowspan="4" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Period           </b>          </td>          <td rowspan="4">          </td>          <td align="center" valign="bottom">           <b>            Total           </b>          </td>          <td rowspan="4">          </td>          <td align="center" colspan="2" valign="bottom">           <b>            Average           </b>          </td>          <td rowspan="4">          </td>          <td align="center" valign="bottom">           <b>            shares purchased           </b>          </td>          <td align="center" colspan="2">           <b>            dollar value of           </b>          </td>         </tr>         <tr>          <td align="center" valign="bottom">           <b>            number           </b>          </td>          <td align="center" colspan="2" valign="bottom">           <b>            price           </b>          </td>          <td align="center" valign="bottom">           <b>            as part of publicly           </b>          </td>          <td align="center" colspan="2">           <b>            shares that may           </b>          </td>         </tr>         <tr>          <td align="center" valign="bottom">           <b>            of shares           </b>          </td>          <td align="center" colspan="2" valign="bottom">           <b>            paid           </b>          </td>          <td align="center" valign="bottom">           <b>            announced           </b>          </td>          <td align="center" colspan="2">           <b>            yet be purchased           </b>          </td>         </tr>         <tr>          <td align="center" style="border-bottom: 1px solid black;" valign="bottom">           <b>            purchased           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           <b>            per share           </b>          </td>          <td align="center" style="border-bottom: 1px solid black;" valign="bottom">           <b>            program           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            under the program           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           April 1, 2020 – June 30, 2020          </td>          <td bgcolor="#ccdaef" width="3%">          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef" width="3%">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef" width="3%">          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef" width="3%">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef">           3,853,459          </td>         </tr>         <tr>          <td valign="top">           July 1, 2020 – September 30, 2020          </td>          <td>          </td>          <td align="right">           1,806          </td>          <td width="3%">          </td>          <td width="1%">           $          </td>          <td align="right">           50.62          </td>          <td width="3%">          </td>          <td align="right">           1,806          </td>          <td width="3%">          </td>          <td width="1%">           $          </td>          <td align="right">           3,762,040          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           October 1, 2020 – December 31, 2020          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">           $          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">           $          </td>          <td align="right" bgcolor="#ccdaef">           3,762,040          </td>         </tr>         <tr>          <td valign="top">           January 1, 2021 – March 31, 2021          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;">           -          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           -          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;">           -          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           3,762,040          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="2" valign="top">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           1,806          </td>          <td bgcolor="#ccdaef" colspan="4" valign="top">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           1,806          </td>          <td bgcolor="#ccdaef" colspan="3" valign="top">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         11        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a name="item7">         </a>         ITEM7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTSOF OPERATIONS.        </b>        <br/>        You should read this discussion together with ourfinancial statements and notes included elsewhere in this Report. In additionto historical information, the following discussion contains forward-looking informationthat involves risks and uncertainties. Our actual future results could differmaterially from those presently anticipated due to a variety of factors, includingthose discussed in Item 1A of this Report.        <br/>        <br/>        <b>         General        </b>        <br/>        We develop and sell devices that use “spintronics,”a nanotechnology that relies on electron spin rather than electron charge to acquire,store, and transmit information. We manufacture high-performance spintronic productsincluding sensors and couplers to revolutionize data sensing and transmission.We also receive contracts for research and development and are a licensor of spintronicmagnetoresistive random access memory technology, commonly known as MRAM.        <br/>        <br/>        <b>         Application of Critical Accounting Policies and Estimates        </b>        <br/>        In accordance with SEC guidance, those materialaccounting policies that we believe are the most critical to an investor’sunderstanding of our financial results and condition and require complex managementjudgment are discussed below.        <br/>        <br/>        <i>         <b>          Investment Valuation         </b>        </i>        <br/>        Our investments consist primarily of corporate obligations.We have generally invested excess cash in high-quality investment grade long-termmarketable securities with less than five years to maturity. We classify all ofour marketable securities as available-for-sale, thus securities are recordedat fair value and any associated unrealized gain or loss, net of tax, is includedas a separate component of shareholders’ equity, “Accumulated othercomprehensive income.” If we judged a decline in fair value for any securityto be other than temporary, the cost basis of the individual security would bewritten down and a charge recognized to net income. The fair values for our securitiesare determined based on quoted market prices as of the valuation date and observableprices for similar assets. We consider a number of factors in determining whetherother-than-temporary impairment exists, including: credit market conditions; thecredit ratings of the securities; historical default rates for securities of comparablecredit rating; the presence of insurance of the securities and, if insured, thecredit rating and financial condition of the insurer; the effect of market interestrates on the value of the securities; and the duration and extent of any unrealizedlosses. We also consider the likelihood that we will be required to sell the securitiesprior to maturity based on our financial condition and anticipated cash flows.If any of these conditions and estimates change in the future, or, if differentestimates are used, the fair value of the investments may change significantlyand could result in other-than-temporary decline in value, which could have anadverse impact on our results of operations.        <br/>        <br/>        <b>         <i>          Inventory Valuation         </i>        </b>        <br/>        Inventories are stated at the lower of cost or netrealizable value. Cost is determined by the first in, first out method. Wherethere is evidence that inventory could be disposed of at less than carrying value,the inventory is written down to the net realizable value in the current period.Additionally, we periodically examine our inventory in the context of inventoryturnover, sales trends, competition and other market factors, and we record provisionsto inventory reserve when we determine certain inventory is unlikely to be sold.If reserved inventory is subsequently sold, corresponding reductions in inventoryand inventory reserves are made. Our inventory reserve was $230,000as of March 31, 2021 and $210,000 as of March 31, 2020.        <br/>        <br/>        <b>         <i>          Deferred Tax Assets Estimation         </i>        </b>        <br/>        In determining the carrying value of our net deferredtax assets, we must assess the likelihood of sufficient future taxable incomein certain tax jurisdictions, based on estimates and assumptions to realize thebenefit of these assets. We evaluate the realizability of the deferred assetsquarterly and assess the need for valuation allowances or reduction of existingallowances quarterly. No valuation allowance was recorded as we believe it ismore likely than not that all of the deferred tax assets will be realized.        <br/>        <br/>        We had $73,538 of net deferred tax assets as ofMarch 31, 2021 and $108,119 as of March 31, 2020. Net deferred tax assetsincluded $75,189 in deferred tax assets for stock-based compensation deductionsas of March 31, 2021 and $65,218 as of March 31, 2020.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         12        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <b>         <a name="resultoperations">          Results of Operations         </a>        </b>        <br/>        The following table summarizes the percentage ofrevenue and year-to-year changes for various items for the last two fiscal years:        <br/>        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="2" width="29%">          </td>          <td align="center" colspan="5" style="border-bottom: 1px solid black;">           <b>            Percentageof Revenue            <br/>            Year Ended March 31           </b>          </td>          <td rowspan="2">          </td>          <td align="center" colspan="2" rowspan="2" style="border-bottom: 1px solid black;">           <b>            Year-            <br/>            to-Year            <br/>            Change           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           <b>            2021           </b>          </td>          <td width="4%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           <b>            2020           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="9">           Revenue          </td>         </tr>         <tr>          <td width="30%">           <div style="margin-left: 9pt;">            Product sales           </div>          </td>          <td align="right" width="9%">           96.1          </td>          <td width="1%">           %          </td>          <td width="4%">          </td>          <td align="right" width="9%">           96.0          </td>          <td width="1%">           %          </td>          <td width="4%">          </td>          <td align="right" width="7%">           (15.8          </td>          <td width="1%">           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Contract research and development           </div>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           3.9          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           4.0          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (18.4          </td>          <td>           )%          </td>         </tr>         <tr>          <td>           Total revenue          </td>          <td align="right" width="9%">           100.0          </td>          <td>           %          </td>          <td>          </td>          <td align="right" width="9%">           100.0          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           (15.9          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Cost of sales          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           19.3          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           19.2          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (15.7          </td>          <td>           )%          </td>         </tr>         <tr>          <td>           Gross profit          </td>          <td align="right" width="9%">           80.7          </td>          <td>           %          </td>          <td>          </td>          <td align="right" width="9%">           80.8          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           (16.0          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td colspan="9">           Expenses          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Research and development           </div>          </td>          <td align="right" width="9%">           14.9          </td>          <td>           %          </td>          <td>          </td>          <td align="right" width="9%">           14.5          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           (13.7          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Selling, general, and administrative           </div>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           6.2          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           5.2          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (0.1          </td>          <td>           )%          </td>         </tr>         <tr>          <td>           Total expenses          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           21.1          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           19.7          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (10.1          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Income from operations          </td>          <td align="right" width="9%">           59.6          </td>          <td>           %          </td>          <td>          </td>          <td align="right" width="9%">           61.1          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           (17.9          </td>          <td>           )%          </td>         </tr>         <tr>          <td>           Interest income          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           7.1          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           7.0          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (16.2          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Income before taxes          </td>          <td align="right" width="9%">           66.7          </td>          <td>           %          </td>          <td>          </td>          <td align="right" width="9%">           68.1          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           (17.7          </td>          <td>           )%          </td>         </tr>         <tr>          <td>           Income tax provision          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           12.0          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           10.9          </td>          <td style="border-bottom: 1px solid black;">           %          </td>          <td>          </td>          <td align="right">           (8.2          </td>          <td>           )%          </td>         </tr>         <tr bgcolor="#ccdaef" valign="top">          <td>           Net income          </td>          <td align="right" style="border-bottom: 3px double black;" width="9%">           54.7          </td>          <td style="border-bottom: 3px double black;">           %          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;" width="9%">           57.2          </td>          <td style="border-bottom: 3px double black;">           %          </td>          <td>          </td>          <td align="right">           (19.5          </td>          <td>           %          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        Total revenue for fiscal 2021 decreased 16% comparedto fiscal 2020 due to a 16% decrease in product sales and a 18% decrease in contractresearch and development revenue. The decrease in product sales was primarilydue to decreased purchases by existing customers. The decrease in contract researchand development revenue was due to the completion of certain contracts.        <br/>        <br/>        Total expenses decreased 10% for fiscal 2021 comparedto fiscal 2020 due primarily to a 14% decrease in research and development expense.The decrease in research and development expense was primarily due to the completionof certain new-product development projects.        <br/>        <br/>        Interest income for fiscal 2021 decreased 16% dueto a decrease in our available-for-sale securities and a decrease in the averageinterest rates on those securities.        <br/>        <br/>        Our effective tax rate for fiscal 2021 was 18% ofincome before taxes compared to 16% for fiscal 2020. The smaller effective ratefor fiscal 2020 was due to tax benefits from the Federal Tax Reform Act enactedin 2017. We currently expect our tax rate for fiscal 2022 to be approximately18%.        <br/>        <br/>        The decrease in net income in fiscal 2021 comparedto the prior year was primarily due to decreases in revenue and interest income,partially offset by a decrease in total expenses.        <br/>        <br/>        <b>         The Impact of the COVID-19 Pandemic        </b>        <br/>        We believe the COVID-19 pandemic had a significantimpact on total revenue and net income for fiscal 2021 due to its effects on marketconditions in certain industries, especially medical devices. We believe the effectsof the pandemic on our business began to subside in the second half of fiscal2021.        <br/>        <br/>        <a name="liquidity">        </a>        <b>         Liquidity and Capital Resources        </b>        <br/>        <b>         <i>          Overview         </i>        </b>        <br/>        Cash and cash equivalents were $10,427,340 as ofMarch 31, 2021 compared to $8,065,594 as of March 31, 2020. The $2,361,746increase in cash and cash equivalents was due to $13,364,832 in net cash providedby operating activities and $8,424,873 net cash provided by investing activities,partially offset by $19,427,959 net cash used in financing activities.        <br/>        <br/>        <b>         <i>          Operating Activities         </i>        </b>        <br/>        Net cash provided by operating activities relatedto product sales and research and development contract revenue as our primarysource of working capital for fiscal 2021 and 2020. Net cash provided by operatingactivities was $13,364,832 for fiscal 2021 and $15,895,773 for fiscal 2020.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         13        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        Accounts receivable decreased $729,737 primarilydue to the timing of sales to and payments from customers.        <br/>        <br/>        <i>         <b>          Investing Activities         </b>        </i>        <br/>        Net cash provided by investing activities in fiscal2021 was due to marketable security maturities of $19,000,000, partially offsetby marketable security purchases of $10,512,400 and fixed assets purchases of$62,727.        <br/>        <br/>        Purchases of fixed assets were $62,727 in fiscal2021 and $52,041 in fiscal 2020. Purchases were primarily for capital equipmentand leasehold improvements and were financed with cash provided by operating activities.Our capital expenditures have been significantly higher in prior years and canvary from year to year depending on our needs and equipment purchasing opportunities.        <br/>        <br/>        <b>         <i>          Financing Activities         </i>        </b>        <br/>        Net cash used in financing activities in fiscal2021 was due to $19,336,540 in cash dividends to shareholders and $91,419 in repurchasesof our common stock.        <br/>        <br/>        In addition to cash dividends to shareholders paidin fiscal 2021, on May 5, 2021 we announced that our Board had declared acash dividend of $1.00 per share of Common Stock, or $4,833,232 based on sharesoutstanding as of April 30, 2021, to be paid May 31, 2021. We plan tofund dividends through cash provided by operating activities and proceeds frommaturities of marketable securities. All future dividends will be subject to Boardapproval and subject to the company’s results of operations, cash and marketablesecurity balances, estimates of future cash requirements, the impacts of the COVID-19pandemic, and other factors the Board may deem relevant. Furthermore, dividendsmay be modified or discontinued at any time without notice.        <br/>        <br/>        We believe our working capital and cash generatedfrom operations will be adequate for our needs at least through fiscal 2022.        <br/>        <br/>        <b>         <a name="item8">         </a>         ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.        </b>        <br/>        Financial statements and accompanying notes areincluded in this Report beginning on page F-1.        <br/>        <br/>        <b>         <a name="item9">         </a>         ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ONACCOUNTING AND FINANCIAL DISCLOSURE.        </b>        <br/>        None.        <br/>        <br/>        <b>         <a name="item9A">         </a>         ITEM 9A. CONTROLS AND PROCEDURES.         <br/>         Disclosure Controls and Procedures        </b>        <br/>        Management, with the participation of the ChiefExecutive Officer and Chief Financial Officer, has performed an evaluation ofour disclosure controls and procedures that are defined in        <font style="white-space: nowrap;">         Rules13a-15(e)        </font>        and        <font style="white-space: nowrap;">         15d-15(e)        </font>        of theSecurities Exchange Act of 1934 (the “Exchange Act”) as of the end ofthe period covered by this Report. This evaluation included consideration of thecontrols, processes, and procedures that are designed to ensure that informationrequired to be disclosed by us in the reports we file under the Exchange Act isrecorded, processed, summarized, and reported within the time periods specifiedin the SEC’s rules and forms and that such information is accumulated andcommunicated to our management, including our Chief Executive Officer and ChiefFinancial Officer, as appropriate to allow timely decisions regarding requireddisclosure. Based on such evaluation, our Chief Executive Officer and Chief FinancialOfficer concluded that, as of March 31, 2021, our disclosure controls andprocedures were effective.        <br/>        <br/>        <b>         Management’s Report on Internal Control Over Financial Reporting        </b>        <br/>        Our management is responsible for establishing andmaintaining adequate internal control over financial reporting, as such term isdefined in        <font style="white-space: nowrap;">         Rule 13a-15(f)        </font>        under theExchange Act. Our management, including our Chief Executive Officer and ChiefFinancial Officer, assessed the effectiveness of our internal control over financialreporting as of March 31, 2021. In making this assessment, management usedthe criteria set forth by the Committee of Sponsoring Organizations of the TreadwayCommission (COSO) in the 2013        <i>         Internal Control—Integrated Framework        </i>        .Based on our assessment using the criteria set forth by COSO in the 2013        <i>         InternalControl—Integrated Framework        </i>        , management concluded that our internalcontrol over financial reporting was effective as of March 31, 2021.        <br/>        <br/>        <b>         <a name="item9B">         </a>         ITEM 9B. OTHER INFORMATION.        </b>        <br/>        Effective as of April 30, 2021 we executed AmendmentNo. 7 to our Supplier Partnering Agreement dated January 3, 2006 byand between Pacesetter, Inc., now a subsidiary of Abbott Laboratories, andus, as amended by Amendment No. 1 to the Agreement dated September 6,2007, Amendment No. 2 dated December 15, 2009, Amendment No. 3 datedSeptember 13, 2010, Amendment No. 4 dated February 1, 2011, AmendmentNo. 5 dated April 20, 2016, and Amendment No. 6 dated December 18,2020. We supply products to Abbott Laboratories under the Supplier PartneringAgreement as amended. The Amendment extends the Supplier Partnering Agreementterm through November 30, 2021. The Amendment is filed as Exhibit 10.18 tothis Annual Report on Form 10-K.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         14        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        Our management, including our Chief Executive Officerand Chief Financial Officer, does not expect that our internal control over financialreporting will prevent all errors and all fraud. A control system, no matter howwell conceived and operated, can provide only reasonable, not absolute, assurancethat the objectives of the control system are met. Further, the design of a controlsystem must reflect the fact that there are resource constraints, and the benefitsof controls must be considered relative to their costs. Because of the inherentlimitations in all control systems, no evaluation of controls can provide absoluteassurance that all control issues and instances of fraud, if any, within NVE havebeen detected. Our internal controls over financial reporting, however, are designedto provide reasonable assurance that the objectives of internal control over financialreporting are met.        <br/>        <br/>        <b>         Changes in Internal Controls        </b>        <br/>        During the quarter ended March 31, 2021, therewas no change in our internal control over financial reporting that materiallyaffected, or is reasonably likely to materially affect, our internal control overfinancial reporting.        <br/>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <u>           <a name="part3">            PARTIII           </a>          </u>         </b>        </font>       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <b>         <a name="item10">          ITEM 10.         </a>         DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.        </b>        <br/>        The section titled “Proposal 1. Electionof Board of Directors” to be included in our Proxy Statement for our 2021Annual Meeting of Shareholders sets forth certain information regarding our directorsand executive officers required by Item 10, the section titled “InformationAbout Our Executive Officers” sets forth information regarding our executiveofficers required by Item 10, and the section titled “Corporate Governance”sets forth information regarding our corporate governance and code of ethics requiredby Item 10. The information in these sections to be included in our ProxyStatement for our 2021 Annual Meeting of Shareholders are incorporated by referenceinto this section.        <br/>        <br/>        <b>         <a name="item11">          ITEM 11.         </a>         EXECUTIVE COMPENSATION.        </b>        <br/>        The information in the sections “ExecutiveCompensation,” “Compensation Discussion and Analysis,” “CorporateGovernance – Board Committees – Compensation Committee Interlocksand Insider Participation,” and “Director Compensation” to be includedin our Proxy Statement for our 2021 Annual Meeting of Shareholders is incorporatedby reference into this section.        <br/>        <br/>        <b>         <a name="item12">          ITEM 12.         </a>         SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERSAND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.        </b>        <br/>        The information in the sections “Equity CompensationPlan Information” and “Security Ownership” to be included in ourProxy Statement for our 2021 Annual Meeting of Shareholders is incorporated byreference into this section. Information regarding the material features of our2000 Stock Option Plan, as amended, is contained in Note 5 to the FinancialStatements included elsewhere in this Report.        <br/>        <br/>        <b>         <a name="item13">          ITEM 13.         </a>         CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS,AND DIRECTOR INDEPENDENCE.        </b>        <br/>        The information in the sections “Security Ownership –Transactions With Related Persons, Promoters, and Certain Control Persons”and “Corporate Governance – Board Composition and Independence”to be included in our Proxy Statement for our 2021 Annual Meeting of Shareholdersis incorporated by reference into this section.        <br/>        <br/>        <b>         <a name="item14">          ITEM 14.         </a>         PRINCIPAL ACCOUNTING FEES AND SERVICES.        </b>        <br/>        The information in the sections “Audit CommitteeDisclosure – Fees Billed to Us by Our Independent Registered PublicAccounting Firm During Fiscal 2020 and 2019” and “Audit Committee Disclosure –Audit Committee Pre-Approval Policy” to be included in our Proxy Statementfor our 2021 Annual Meeting of Shareholders is incorporated by reference intothis section.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Arial, Helvetica;">         <b>          <u>           <a name="itemIV">            PARTIV           </a>          </u>         </b>         <br/>         <br/>        </font>       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a name="item15">          ITEM15.         </a>         EXHIBITS, FINANCIAL STATEMENT SCHEDULES.         <br/>         (a) Financial Statements and Schedules        </b>        <br/>        Financial statements are provided pursuant to Item 8of this Report. Certain financial statement schedules have been omitted becausethey are not required, not applicable, or the required information is providedin other financial statements or the notes to the financial statements.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         15        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a href="#TOC">          Tableof Contents         </a>        </b>        <br/>        <br/>        <b>         (b) Exhibits        </b>        <br/>        The following is a list of exhibits:        <br/>       </font>       <font style="font-size: 2pt; font-family: Times New Roman">        <br/>       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman;" width="100%">        <tbody>         <tr>          <td style="border-bottom: 1px solid black;" width="1%">           <b>            Exhibit #           </b>          </td>          <td align="center" style="border-bottom: 1px solid black;">           <b>            Description           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           3.1          </td>          <td bgcolor="#ccdaef">           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491003000001/articles-a.txt">            Amendedand Restated Articles of Incorporation of the company as amended by the Boardof Directors effective November 21, 2002 (incorporated by reference to theForm 10-QSB for the period ended December 31, 2002).           </a>          </td>         </tr>         <tr>          <td valign="top">           3.2          </td>          <td>           <a href="https://www.sec.gov/Archives/edgar/data/724910/000072491020000015/blaws-20.htm">            Bylawsof the company as amended by the Board of Directors effective May 6, 2020.           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           4          </td>          <td>           <a href="ex4.htm">            Description of the registrant’s securities registeredpursuant to Section 12 of the Securities Exchange Act of 1934.           </a>          </td>         </tr>         <tr>          <td valign="top">           10.1          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491002000010/oldlease.txt">            Leasedated October 1, 1998 between the company and Glenborough Properties, LP (incorporatedby reference to the Form 10-QSB for the period ended September 30, 2002).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.2          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491002000010/newlease.txt">            Firstamendment to lease between the company and Glenborough dated September 18,2002 (incorporated by reference to the Form 10-QSB for the period ended September 30,2002).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.3          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491004000005/a-2lease.txt">            Secondamendment to lease between the company and Glenborough dated December 1, 2003(incorporated by reference to the            <font style="white-space: nowrap;">             Form 10-QSB            </font>            for the period ended December 31, 2003).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.4          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491007000020/lease-3.htm">            Thirdamendment to lease between the company and Carlson Real Estate (incorporated byreference to the Form 8-K/A filed December 20, 2007).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.5          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491011000022/lease-4.htm">            Fourthamendment to lease between the company and the Barbara C. Gage Revocable Trust(incorporated by reference to our Current Report on Form 8-K/A filed August 3,2011).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.6          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491011000022/lease-4.htm">            Fifthamendment to lease between the company and GRE – Bryant Lake, LLC (incorporatedby reference to our Current Report on Form 8-K/A filed March 3, 2020).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.7†          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491001500010/nvebaker.txt">            EmploymentAgreement between the company and Daniel A. Baker dated January 29, 2001(incorporated by reference to the Form 10-KSB for the year ended March 31,2001).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.8†          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491001500016/amndplan.txt">            NVECorporation 2000 Stock Option Plan as Amended July 19, 2001 by the shareholders(incorporated by reference to our Registration Statement on Form S-8 filed July 20,2001).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.9          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491005000021/sjm-ind05.txt">            IndemnificationAgreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a.St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporatedby reference to the Form 8-K filed September 27, 2005).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.10+          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491006000003/sjm-agmt.txt">            SupplierPartnering Agreement by and between St. Jude and the company (incorporatedby reference to the            <font style="white-space: nowrap;">             Form 8-K            </font>            filed January 4,2006).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.11+          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491007000015/sjm-a1.htm">            AmendmentNo. 1 to Supplier Partnering Agreement between St. Jude and the company (incorporatedby reference to the Form 8-K/A filed September 10, 2007).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.12+          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491009000021/sjm-a2.htm">            AmendmentNo. 2 to Supplier Partnering Agreement between St. Jude and the company (incorporatedby reference to the Form 8-K/A filed December 18, 2009).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.13+          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491010000022/sjm-a3.htm">            AmendmentNo. 3 to Supplier Partnering Agreement between St. Jude and the company (incorporatedby reference to the Form 8-K/A filed September 16, 2010).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.14          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491011000006/sjm-a4.htm">            AmendmentNo. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporatedby reference to the Form 8-K/A filed February 7, 2011).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.15          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491016000046/stj-sqa.htm">            SupplierQuality Agreement between St. Jude and the company (incorporated by referenceto the Form 8-K filed February 10, 2016).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.16          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491016000048/stj-a5.htm">            AmendmentNo. 5 to Supplier Partnering Agreement between St. Jude and the company (incorporatedby reference to the Form 8-K/A filed April 21, 2016).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.17          </td>          <td>           <a href="https://www.sec.gov/Archives/edgar/data/724910/000072491020000041/stj-a6.htm">            AmendmentNo. 6 to Supplier Partnering Agreement between Abbott and the company (incorporatedby reference to the Form 8-K/A filed December 21, 2020).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.18          </td>          <td>           <a href="stj-a7.htm">            Amendment No. 7 to Supplier Partnering Agreement betweenAbbott and the company (filed with this Annual Report on Form 10-K).           </a>          </td>         </tr>         <tr>          <td valign="top">           10.19+          </td>          <td>           <a href="http://www.sec.gov/Archives/edgar/data/724910/000072491015000040/phonak15.htm">            SupplyAgreement by and between the company and Sonova AG (incorporated by referenceto the            <font style="white-space: nowrap;">             Form 8-K/A            </font>            filed November 16,2015).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           10.20*          </td>          <td>           <a href="https://www.sec.gov/Archives/edgar/data/724910/000072491020000008/sonova20.htm">            FirstAmendment to Supply Agreement by and between the company and Sonova AG (incorporatedby reference to the            <font style="white-space: nowrap;">             Form 8-K/A            </font>            filedFebruary 18, 2020).           </a>          </td>         </tr>         <tr>          <td valign="top">           23.1          </td>          <td>           <a href="ex23.htm">            Consent of Boulay PLLP.           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           31.1          </td>          <td>           <a href="ex31-dab.htm">            Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).           </a>          </td>         </tr>         <tr>          <td valign="top">           31.2          </td>          <td>           <a href="ex31-car.htm">            Certification by Curt A. Reynders pursuant to Rule13a-14(a)/15d-14(a).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           32          </td>          <td>           <a href="ex32.htm">            Certification by Daniel A. Baker and Curt A. Reynders pursuantto 18 U.S.C. Section 1350.           </a>          </td>         </tr>         <tr>          <td valign="top">           101.INS          </td>          <td>           XBRL Instance Document          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.SCH          </td>          <td>           XBRL Taxonomy Extension Schema Document          </td>         </tr>         <tr>          <td valign="top">           101.CAL          </td>          <td>           XBRL Taxonomy Extension Calculation Linkbase Document          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.DEF          </td>          <td>           XBRL Taxonomy Extension Definition Linkbase Document          </td>         </tr>         <tr>          <td valign="top">           101.LAB          </td>          <td>           XBRL Taxonomy Extension Label Linkbase Document          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.PRE          </td>          <td>           XBRL Taxonomy Extension Presentation Linkbase Document          </td>         </tr>        </tbody>       </table>       <table border="0" cellpadding="0" cellspacing="00" style="font-size:2pt;" width="80">        <tbody>         <tr>          <td style="border:none;border-bottom:solid windowtext 1.0pt;padding:0pt .2pt 0pt 0pt;">          </td>         </tr>         <tr>          <td height="4">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        †Indicates amanagement contract or compensatory plan or arrangement.        <br/>        <font style="font-size: 2pt; font-family: Times New Roman">         <br/>        </font>        +Confidential portions deleted and filed separately with the SEC.        <br/>        <font style="font-size: 2pt; font-family: Times New Roman">         <br/>        </font>        *Certain confidential portions redacted pursuant to Item 601(b)(10)(iv) of RegulationS-K. The omitted information is (i) not material and (ii) would likelycause us competitive harm if publicly disclosed. We agree to furnish supplementallyan unredacted copy of the exhibit to the Securities and Exchange Commission onits request.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         16        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <b>         ITEM 16. FORM 10-K SUMMARY.        </b>        <br/>        We have elected not to include an optional Form10-K Summary.        <br/>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <a name="signatures">           SIGNATURES          </a>         </b>        </font>       </div>       <br/>       <font style="font-size: 10pt; font-family: Times New Roman">        Pursuantto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,the registrant has duly caused this report to be signed on its behalf by the undersigned,thereunto duly authorized.        <br/>        <br/>        <div style="margin-left: 144pt;">         <b>          <u>           NVE CORPORATION          </u>         </b>         <br/>         (Registrant)         <br/>         <br/>         <u>          /s/Daniel A. Baker         </u>         <br/>         by Daniel A. Baker         <br/>         President and Chief Executive Officer         <br/>         <br/>         Date    May 5, 2021        </div>        <br/>        <br/>        <br/>        Pursuant to the requirements of the Securities ExchangeAct of 1934, this report has been signed below by the following persons on behalfof the registrant and in the capacities and on the dates indicated.        <br/>        <br/>       </font>       <table cellpadding="5" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td align="center" valign="top" width="33%">           <b>            <u>             Name            </u>           </b>          </td>          <td align="center" valign="top">           <b>            <u>             Title            </u>           </b>          </td>          <td align="center" width="33%">           <b>            <u>             Date            </u>           </b>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Terrence W. Glarner           </u>           <br/>           Terrence W. Glarner          </td>          <td align="center" valign="top">           Director and           <br/>           Chairman of the Board           <br/>           <br/>          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Daniel A. Baker           </u>           <br/>           Daniel A. Baker          </td>          <td align="center" valign="middle">           Director,           <br/>           President &amp; Chief Executive Officer           <br/>           (Principal Executive Officer)           <br/>          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Curt A. Reynders           </u>           <br/>           Curt A. Reynders          </td>          <td align="center" valign="top">           Treasurer and           <br/>           Chief Financial Officer           <br/>           (Principal Financial and           <br/>           Accounting Officer)          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Patricia M. Hollister           </u>           <br/>           Patricia M. Hollister           <br/>           <br/>          </td>          <td align="center" valign="top">           Director          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Richard W. Kramp           </u>           <br/>           Richard W. Kramp           <br/>           <br/>          </td>          <td align="center" valign="top">           Director          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>         <tr>          <td align="center" valign="top">           <u>            /s/Gary R. Maharaj           </u>           <br/>           Gary R. Maharaj          </td>          <td align="center" valign="top">           Director          </td>          <td align="center" valign="top">           <u>            May 5, 2021           </u>          </td>         </tr>        </tbody>       </table>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         <br/>         17        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <a name="Report">        </a>        <br/>       </font>       <img alt="Boulay Logo" height="119" src="boulay.gif" width="65"/>       <font style="font-size: 10pt; font-family: Arial, Helvetica;">        <br/>        <br/>        <b>         REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM        </b>       </font>       <font style="font-size: 10pt; font-family: Times New Roman, Times, serif;">        <br/>        <br/>        To the Board of Directors and Shareholders of        <br/>        NVE Corporation        <br/>        <br/>        <b>         Opinion on the Financial Statements        </b>        <br/>        We have audited the accompanying balance sheets of NVE Corporation (the Company)as of March 31, 2021 and 2020, and the related statements of income, comprehensiveincome, shareholders' equity, and cash flows for each of the years in thetwo-year period ended March 31, 2021, and the related notes (collectively referredto as the financial statements). In our opinion, the financial statements presentfairly, in all material respects, the financial position of the Company as ofMarch 31, 2021 and 2020, and the results of its operations and its cash flowsfor each of the years in the two-year period ended March 31, 2021, in conformitywith accounting principles generally accepted in the United States of America.        <br/>        <br/>        <b>         Basis for Opinion        </b>        <br/>        These financial statements are the responsibility of the Company’s management.Our responsibility is to express an opinion on the Company’s financial statementsbased on our audits. We are a public accounting firm registered with the PublicCompany Accounting Oversight Board (United States) (PCAOB) and are required tobe independent with respect to the Company in accordance with the U.S. federalsecurities laws and the applicable rules and regulations of the Securities andExchange Commission and the PCAOB.        <br/>        <br/>        We conducted our audits in accordance with the standards of the PCAOB. Those standardsrequire that we plan and perform the audit to obtain reasonable assurance aboutwhether the financial statements are free of material misstatement, whether dueto error or fraud. The Company is not required to have, nor were we engaged toperform, an audit of its internal control over financial reporting. As part ofour audits, we are required to obtain an understanding of internal control overfinancial reporting, but not for the purpose of expressing an opinion on the effectivenessof the Company’s internal control over financial reporting. Accordingly,we express no such opinion.        <br/>        <br/>        Our audits included performing procedures to assess the risks of material misstatementof the financial statements, whether due to error or fraud, and performing proceduresthat respond to those risks. Such procedures included examining, on a test basis,evidence regarding the amounts and disclosures in the financial statements. Ouraudits also included evaluating the accounting principles used and significantestimates made by management, as well as evaluating the overall presentation ofthe financial statements. We believe that our audits provide a reasonable basisfor our opinion.        <br/>        <br/>        <b>         Critical Audit Matter        </b>        <br/>        The critical audit matter communicated below is a matter arising from the currentperiod audit of the financial statements that was communicated or required tobe communicated to the audit committee and that: (1) related to accounts or disclosuresthat are material to the financial statements and (2) involved our especiallychallenging, subjective, or complex judgments. The communication of critical auditmatters does not alter in any way our opinion on the financial statements, takenas a whole, and we are not, by communicating the critical audit matter below,providing separate opinions on the critical audit matter or on the accounts ordisclosures to which it relates.        <br/>        <br/>        <div align="center">         Revenue Recognition – Refer to Note 1 to the FinancialStatements        </div>        <br/>        <b>         Description of the Matter        </b>        <br/>        The Company recognizes revenue from product sales to customers and distributorsupon satisfaction of the performance obligation, at a point in time, upon productshipment or delivery to its customer or distributor as determined by agreed uponshipping terms. Additionally, the Company recognizes contract research and developmentrevenue over a period of time as the performance obligation is satisfied overa period of time. Each research and development contract has specifications uniqueto each customer and does not create an asset with an alternate use, and the Companyhas an enforceable right to payment for performance completed to date. The Companyrecognizes revenue over a period of time based on an input method using costsincurred as the measurement of progress towards completion.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-1        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman, Times, serif;">        <br/>        Significantjudgment is exercised by the Company in determining revenue recognition for thesecustomer agreements, and includes the following:        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="4" width="2">          </td>          <td valign="top" width="2">           •          </td>          <td>           Determination of whether products and services are considered distinct performanceobligations that should be accounted for separately versus together as it relatesto product sales and research and development contracts.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           Determination of stand-alone selling prices for each distinct performanceobligation and for products and services that are not sold separately.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           The pattern of delivery (i.e., timing of when revenue is recognized) for eachdistinct performance obligation.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td>           Estimation of variable consideration when determining the amount of revenueto recognize (e.g., customer credits, incentives, and in certain instances, estimationof customer usage of products and services).          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman, Times, serif;">        <br/>        Given these factors, the related audit effort in evaluating management’sjudgments in determining revenue recognition for these customer agreements wasextensive and required a high degree of auditor judgment.        <br/>        <br/>        <b>         How the Critical Audit Matter Was Addressed in the Audit        </b>        <br/>        Our principal audit procedures related to the Company’s revenue recognitionfor these customer agreements included the following:        <br/>       </font>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="5" width="2">          </td>          <td valign="top" width="2">           •          </td>          <td colspan="3">           We evaluated the Company’s accounting policies and relateddisclosures for compliance with applicable revenue recognition accounting guidance.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td colspan="3">           We obtained an understanding of the design and implementationof internal controls related to the Company’s revenue recognition process,including the identification of performance obligations and allocation of transactionprice.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td colspan="3">           We performed analytical procedures to test the reasonablenessof recorded balances.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td colspan="3">           We performed procedures to test the transactions were recordedin the appropriate accounting period.          </td>         </tr>         <tr>          <td valign="top">           •          </td>          <td colspan="3">           We selected a sample of product sales and contract research agreementsand performed the following procedures:          </td>         </tr>        </tbody>       </table>       <table border="0" cellpadding="0" cellspacing="00" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="5" width="10">          </td>          <td valign="top" width="2">           –          </td>          <td>           Tested the existence and accuracy of the transaction by obtaining and agreeingterms to the underlying contract.          </td>         </tr>         <tr>          <td valign="top">           –          </td>          <td>           Evaluated management’s identification of significant terms for completeness,including the identification of distinct performance obligations and variableconsideration.          </td>         </tr>         <tr>          <td valign="top">           –          </td>          <td>           We evaluated the reasonableness of management’s estimate of stand-aloneselling prices for products and services that are not sold separately.          </td>         </tr>         <tr>          <td valign="top">           –          </td>          <td>           Tested the underlying costs driving recognition of revenue related to contractresearch and development contracts.          </td>         </tr>         <tr>          <td valign="top">           –          </td>          <td>           Evaluated whether the transaction was accounted for in accordance with theCompany’s policies.          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman, Times, serif;">        <br/>        <br/>        /s/ Boulay PLLP        <br/>        We have served as the Company’s auditor since May 8, 2019.        <br/>        <br/>        Minneapolis, Minnesota        <br/>        May 5, 2021        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-2        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <a name="BS">           NVECORPORATION          </a>          <br/>          BALANCE SHEETS         </b>         <br/>        </font>       </div>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;" valign="bottom">           <b>            March31, 2021           </b>          </td>          <td width="2%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;" valign="bottom">           <b>            March31, 2020           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           ASSETS          </td>         </tr>         <tr>          <td colspan="8">           Current assets          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Cash and cash equivalents           </div>          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" width="11%">           10,427,340          </td>          <td bgcolor="#ccdaef" width="1%">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" width="11%">           8,065,594          </td>          <td bgcolor="#ccdaef" width="1%">          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Marketable securities, short-term           </div>          </td>          <td>          </td>          <td align="right">           7,678,957          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           19,084,814          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Accounts receivable, net of allowance for uncollectibleaccounts of $15,000           </div>          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           1,964,281          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           2,694,018          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Inventories           </div>          </td>          <td>          </td>          <td align="right">           3,900,777          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           3,884,450          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Prepaid expenses and other assets           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           391,278          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           655,835          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Total current assets          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;">           24,362,633          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;">           34,384,711          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Fixed assets          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Machinery and equipment           </div>          </td>          <td>          </td>          <td align="right">           9,254,664          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           9,280,062          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Leasehold improvements           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           1,810,872          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           1,797,245          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>          </td>          <td>          </td>          <td align="right">           11,065,536          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           11,077,307          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Less accumulated depreciation and amortization           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           10,728,853          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           10,494,840          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Net fixed assets          </td>          <td>          </td>          <td align="right">           336,683          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           582,467          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Deferred tax assets          </td>          <td align="right" bgcolor="#ccdaef" colspan="2">           73,538          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2">           108,119          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           Marketable securities, long-term          </td>          <td align="right" colspan="2">           47,038,669          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           43,606,495          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Right-of-use asset – operating lease          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           689,216          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           816,358          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr valign="top">          <td>           Total assets          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           72,500,739          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           79,498,150          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">          </td>         </tr>         <tr>          <td colspan="8">           LIABILITIES AND SHAREHOLDERS’ EQUITY          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Current liabilities          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Accounts payable           </div>          </td>          <td>           $          </td>          <td align="right">           336,591          </td>          <td>          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           186,993          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Accrued payroll and other           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2">           540,474          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2">           482,074          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Operating lease           </div>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           150,273          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           127,134          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Total current liabilities          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           1,027,338          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           796,201          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           Operating lease          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           581,459          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           706,600          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Total liabilities          </td>          <td align="right" colspan="2">           1,608,797          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           1,502,801          </td>          <td>          </td>         </tr>         <tr>          <td colspan="8">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td colspan="8">           Shareholders’ equity          </td>         </tr>         <tr>          <td valign="bottom">           <div style="text-indent: -9pt; margin-left: 18pt;">            Common stock, $0.01 par value,6,000,000 shares authorized; 4,833,232 issued            <br/>            and outstanding as of March 31, 2021 and 4,835,038 as of March 31, 2020           </div>          </td>          <td>          </td>          <td align="right" valign="bottom">           48,332          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           48,350          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Additional paid-in capital           </div>          </td>          <td>          </td>          <td align="right">           19,338,127          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           19,383,956          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Accumulated other comprehensive income           </div>          </td>          <td>          </td>          <td align="right" valign="bottom">           1,101,119          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           516,523          </td>          <td valign="bottom">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Retained earnings           </div>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           50,404,364          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           58,046,520          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Total shareholders’ equity          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           70,891,942          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           77,995,349          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Total liabilities and shareholders’ equity          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           72,500,739          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           79,498,150          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>        </tbody>       </table>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         <br/>         <br/>         See accompanying notes.         <br/>         <br/>        </font>       </div>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-3        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <a name="income">           NVECORPORATION          </a>          <br/>          STATEMENTS OF INCOME         </b>         <br/>         <br/>        </font>       </div>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="7" style="border-bottom: 1px solid black;">           <b>            YearEnded March 31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td width="2%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Revenue          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Product sales           </div>          </td>          <td width="1%">           $          </td>          <td align="right" width="11%">           20,540,557          </td>          <td width="1%">          </td>          <td>          </td>          <td width="1%">           $          </td>          <td align="right" width="11%">           24,400,192          </td>          <td width="1%">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Contract research and development           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           825,689          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           1,011,971          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Total revenue          </td>          <td>          </td>          <td align="right">           21,366,246          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           25,412,163          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Cost of sales          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           4,121,461          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           4,889,295          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Gross profit          </td>          <td align="right" colspan="2">           17,244,785          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           20,522,868          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Expenses          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Research and development           </div>          </td>          <td>          </td>          <td align="right">           3,184,754          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           3,690,539          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Selling, general, and administrative           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           1,316,427          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" colspan="2" style="border-bottom: 1px solid black;">           1,317,543          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Total expenses          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           4,501,181          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           5,008,082          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Income from operations          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           12,743,604          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           15,514,786          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           Interest income          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;">           1,498,148          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;">           1,787,117          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Income before taxes          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           14,241,752          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           17,301,903          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td>           Provision for income taxes          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           2,547,368          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           2,775,261          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           Net income          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           11,694,384          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           14,526,642          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>         </tr>         <tr>          <td valign="top">           Net income per share – basic          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           2.42          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           3.00          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           Net income per share – diluted          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           2.42          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           3.00          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>         </tr>         <tr>          <td valign="top">           Cash dividends declared per common share          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           4.00          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           4.00          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Weighted average shares outstanding          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Basic           </div>          </td>          <td align="right" colspan="2">           4,834,054          </td>          <td align="right" colspan="4">           4,845,627          </td>          <td align="right">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Diluted           </div>          </td>          <td align="right" bgcolor="#ccdaef" colspan="2">           4,834,462          </td>          <td align="right" bgcolor="#ccdaef" colspan="4">           4,847,294          </td>          <td align="right" bgcolor="#ccdaef">          </td>         </tr>        </tbody>       </table>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <br/>         <br/>         <b>          <a name="CompIncome">          </a>          STATEMENTS OF COMPREHENSIVE INCOME         </b>         <br/>         <br/>        </font>        <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">         <tbody>          <tr>           <td rowspan="2">           </td>           <td align="center" colspan="7" style="border-bottom: 1px solid black;">            <b>             YearEnded March 31            </b>           </td>          </tr>          <tr>           <td align="center" colspan="3" style="border-bottom: 1px solid black;">            <b>             2021            </b>           </td>           <td width="2%">           </td>           <td align="center" colspan="3" style="border-bottom: 1px solid black;">            <b>             2020            </b>           </td>          </tr>          <tr bgcolor="#ccdaef">           <td>            Net income           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            11,694,384           </td>           <td width="1%">           </td>           <td>           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            14,526,642           </td>           <td width="1%">           </td>          </tr>          <tr>           <td>            Unrealized gain from marketable securities, net of tax           </td>           <td align="right" colspan="2" style="border-bottom: 1px solid black;">            584,596           </td>           <td style="border-bottom: 1px solid black;">           </td>           <td>           </td>           <td align="right" colspan="2" style="border-bottom: 1px solid black;">            599,248           </td>           <td style="border-bottom: 1px solid black;">           </td>          </tr>          <tr bgcolor="#ccdaef">           <td valign="top">            Comprehensive income           </td>           <td style="border-bottom: 3px double black;" valign="top">            $           </td>           <td align="right" style="border-bottom: 3px double black;" valign="top">            12,278,980           </td>           <td style="border-bottom: 3px double black;">           </td>           <td valign="top">           </td>           <td style="border-bottom: 3px double black;" valign="top">            $           </td>           <td align="right" style="border-bottom: 3px double black;" valign="top">            15,125,890           </td>           <td style="border-bottom: 3px double black;">           </td>          </tr>         </tbody>        </table>        <font style="font-size: 10pt; font-family: Times New Roman">         <br/>         <br/>         See accompanying notes.         <br/>         <br/>        </font>       </div>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-4        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <a name="SHE">           NVECORPORATION          </a>          <br/>          STATEMENTS OF SHAREHOLDERS’ EQUITY         </b>         <br/>         <br/>        </font>       </div>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="3">          </td>          <td colspan="4">           <br/>           <br/>          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="2%">          </td>          <td align="center" colspan="2" rowspan="3" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Additional            <br/>            Paid-In            <br/>            Capital           </b>          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="1%">          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="2%">          </td>          <td align="center" colspan="3" rowspan="3" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Accumulated            <br/>            Other            <br/>            Comprehen-            <br/>            sive Income            <br/>            (Loss)           </b>          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="1%">          </td>          <td align="center" colspan="2" rowspan="3" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Retained            <br/>            Earnings            <br/>           </b>          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="1%">          </td>          <td rowspan="3" style="border-bottom: 1px solid black;" width="1%">          </td>          <td colspan="3" rowspan="2">          </td>         </tr>         <tr>          <td align="center" colspan="4" style="border-bottom: 1px solid black;">           <b>            CommonStock           </b>          </td>         </tr>         <tr>          <td align="center" style="border-bottom: 1px solid black;">           <b>            Shares           </b>          </td>          <td style="border-bottom: 1px solid black;" width="2%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Amount           </b>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Total           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           Balance as of March 31, 2019          </td>          <td align="right" valign="top">           4,846,010          </td>          <td>          </td>          <td valign="top">           $          </td>          <td align="right" valign="top">           48,460          </td>          <td valign="top">          </td>          <td>           $          </td>          <td align="right" valign="top">           19,910,558          </td>          <td>          </td>          <td>          </td>          <td>           $          </td>          <td align="right" valign="top">           (82,725          </td>          <td>           )          </td>          <td>          </td>          <td>           $          </td>          <td align="right" valign="top">           62,903,918          </td>          <td>          </td>          <td>          </td>          <td>           $          </td>          <td align="right" valign="top">           82,780,211          </td>          <td>          </td>         </tr>         <tr>          <td valign="bottom">           <div style="margin-left: 9pt;">            Exercise of stock           </div>           <div style="margin-left: 18pt;">            options           </div>          </td>          <td align="right" valign="bottom">           2,000          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           20          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           112,340          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           112,360          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Repurchase of common stock           </div>          </td>          <td align="right" valign="bottom">           (12,972          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td align="right" valign="bottom">           (130          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td align="right" valign="bottom">           (687,302          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           (687,432          </td>          <td valign="bottom">           )          </td>         </tr>         <tr>          <td colspan="21">           <div style="margin-left: 9pt;">            Comprehensive income:           </div>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="bottom">           <div style="margin-left: 27pt;">            Unrealized gain on           </div>           <div style="margin-left: 36pt;">            marketable securities,            <br/>            net of tax           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           599,248          </td>          <td>          </td>          <td align="right" colspan="7" valign="bottom">           599,248          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Net income           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           14,526,642          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           14,526,642          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Total comprehensive income           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           15,125,890          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Stock-based compensation           </div>          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td align="right" colspan="2">           48,360          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           48,360          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="bottom">           <div style="margin-left: 9pt;">            Cash dividends declared           </div>           <div style="margin-left: 18pt;">            ($4.00 per share of            <br/>            common stock)           </div>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td>          </td>          <td colspan="3" style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           (19,384,040          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           (19,384,040          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>         </tr>         <tr>          <td valign="top">           Balance as of March 31, 2020          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           4,835,038          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           48,350          </td>          <td valign="top">          </td>          <td style="border-bottom: 1px solid black;">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           19,383,956          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           516,523          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           58,046,520          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="top">           77,995,349          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Repurchase of common stock           </div>          </td>          <td align="right" valign="bottom">           (1,806          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td align="right" valign="bottom">           (18          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td align="right" valign="bottom">           (91,401          </td>          <td valign="bottom">           )          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           (91,419          </td>          <td valign="bottom">           )          </td>         </tr>         <tr>          <td colspan="21">           <div style="margin-left: 9pt;">            Comprehensive income:           </div>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="bottom">           <div style="margin-left: 27pt;">            Unrealized gain on           </div>           <div style="margin-left: 36pt;">            marketable securities,            <br/>            net of tax           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="bottom">           584,596          </td>          <td>          </td>          <td align="right" colspan="7" valign="bottom">           584,596          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Net income           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           11,694,384          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           11,694,384          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Total comprehensive income           </div>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td>          </td>          <td align="right">           12,278,980          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Stock-based compensation           </div>          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td align="right" colspan="2">           45,572          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td colspan="2">          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           45,572          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="bottom">           <div style="margin-left: 9pt;">            Cash dividends declared           </div>           <div style="margin-left: 18pt;">            ($4.00 per share of            <br/>            common stock)           </div>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td>          </td>          <td colspan="3" style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           (19,336,540          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           (19,336,540          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>         </tr>         <tr>          <td valign="top">           Balance as of March 31, 2021          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           4,833,232          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           48,332          </td>          <td valign="top">          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           19,338,127          </td>          <td>          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           1,101,119          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           50,404,364          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           70,891,942          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>        </tbody>       </table>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         <br/>         <br/>         See accompanying notes.         <br/>         <br/>        </font>       </div>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-5        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          <a name="CF">           NVECORPORATION          </a>          <br/>          STATEMENTS OF CASH FLOWS         </b>         <br/>         <br/>        </font>        <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">         <tbody>          <tr>           <td rowspan="2" width="71%">           </td>           <td align="center" colspan="7" style="border-bottom: 1px solid black;">            <b>             YearEnded March 31            </b>           </td>          </tr>          <tr>           <td align="center" colspan="3" style="border-bottom: 1px solid black;">            <b>             2021            </b>           </td>           <td width="2%">           </td>           <td align="center" colspan="3" style="border-bottom: 1px solid black;">            <b>             2020            </b>           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="8">            OPERATING ACTIVITIES           </td>          </tr>          <tr>           <td>            Net income           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            11,694,384           </td>           <td width="1%">           </td>           <td width="2%">           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            14,526,642           </td>           <td width="1%">           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="8">            Adjustments to reconcile net income to net cash            <div style="margin-left: 9pt;">             provided by operating activities:            </div>           </td>          </tr>          <tr>           <td>            <div style="margin-left: 18pt;">             Depreciation and amortization            </div>           </td>           <td width="1%">           </td>           <td align="right">            542,926           </td>           <td>           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right">            549,969           </td>           <td>           </td>          </tr>          <tr>           <td bgcolor="#ccdaef">            <div style="margin-left: 18pt;">             Stock-based compensation            </div>           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef">            45,572           </td>           <td bgcolor="#ccdaef">           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef">            48,360           </td>           <td bgcolor="#ccdaef">           </td>          </tr>          <tr>           <td>            <div style="margin-left: 18pt;">             Deferred income taxes            </div>           </td>           <td width="1%">           </td>           <td align="right">            (129,155           </td>           <td>            )           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right">            77,779           </td>           <td>           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="8">            <div style="margin-left: 18pt;">             Changes in operating assets and liabilities:            </div>           </td>          </tr>          <tr>           <td>            <div style="margin-left: 36pt;">             Accounts receivable            </div>           </td>           <td width="1%">           </td>           <td align="right" width="11%">            729,737           </td>           <td width="1%">           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right" width="11%">            301,620           </td>           <td>           </td>          </tr>          <tr>           <td bgcolor="#ccdaef">            <div style="margin-left: 36pt;">             Inventories            </div>           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            (16,327           </td>           <td bgcolor="#ccdaef" width="1%">            )           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            380,426           </td>           <td bgcolor="#ccdaef">           </td>          </tr>          <tr>           <td>            <div style="margin-left: 36pt;">             Prepaid expenses and other assets            </div>           </td>           <td width="1%">           </td>           <td align="right" width="11%">            391,699           </td>           <td width="1%">           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right" width="11%">            (394,504           </td>           <td>            )           </td>          </tr>          <tr>           <td bgcolor="#ccdaef">            <div style="margin-left: 36pt;">             Accounts payable and accrued expenses            </div>           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="11%">            105,996           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="11%">            405,481           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           </td>          </tr>          <tr>           <td>            Net cash provided by operating activities           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            13,364,832           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td>           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            15,895,773           </td>           <td style="border-bottom: 1px solid black;">           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="8">           </td>          </tr>          <tr>           <td colspan="8">            INVESTING ACTIVITIES           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="2">            Purchases of fixed assets           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            (62,727           </td>           <td bgcolor="#ccdaef" width="1%">            )           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            (52,041           </td>           <td bgcolor="#ccdaef">            )           </td>          </tr>          <tr>           <td>            Purchases of marketable securities           </td>           <td width="1%">           </td>           <td align="right" width="11%">            (10,512,400           </td>           <td width="1%">            )           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right" width="11%">            (7,196,330           </td>           <td>            )           </td>          </tr>          <tr>           <td bgcolor="#ccdaef">            Proceeds from maturities and sales of marketable securities           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="11%">            19,000,000           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;" width="11%">            12,500,000           </td>           <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           </td>          </tr>          <tr>           <td>            Net cash provided by investing activities           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            8,424,873           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td width="2%">           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            5,251,629           </td>           <td style="border-bottom: 1px solid black;">           </td>          </tr>          <tr>           <td bgcolor="#ccdaef" colspan="8">           </td>          </tr>          <tr>           <td colspan="8">            FINANCING ACTIVITIES           </td>          </tr>          <tr>           <td bgcolor="#ccdaef">            Proceeds from exercise of stock options           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            -           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td bgcolor="#ccdaef" width="2%">           </td>           <td bgcolor="#ccdaef" width="1%">           </td>           <td align="right" bgcolor="#ccdaef" width="11%">            112,360           </td>           <td bgcolor="#ccdaef">           </td>          </tr>          <tr>           <td>            Repurchase of common stock           </td>           <td width="1%">           </td>           <td align="right" width="11%">            (91,419           </td>           <td width="1%">            )           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right" width="11%">            (687,432           </td>           <td>            )           </td>          </tr>          <tr bgcolor="#ccdaef">           <td>            Payment of dividends to shareholders           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            (19,336,540           </td>           <td style="border-bottom: 1px solid black;" width="1%">            )           </td>           <td width="2%">           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            (19,384,040           </td>           <td style="border-bottom: 1px solid black;">            )           </td>          </tr>          <tr>           <td>            Net cash used in financing activities           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            (19,427,959           </td>           <td style="border-bottom: 1px solid black;" width="1%">            )           </td>           <td>           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td align="right" style="border-bottom: 1px solid black;" width="11%">            (19,959,112           </td>           <td style="border-bottom: 1px solid black;">            )           </td>          </tr>          <tr bgcolor="#ccdaef">           <td colspan="8">           </td>          </tr>          <tr>           <td>            Increase in cash and cash equivalents           </td>           <td width="1%">           </td>           <td align="right" width="11%">            2,361,746           </td>           <td width="1%">           </td>           <td width="2%">           </td>           <td width="1%">           </td>           <td align="right" width="11%">            1,188,290           </td>           <td>           </td>          </tr>          <tr bgcolor="#ccdaef">           <td>            Cash and cash equivalents at beginning of year           </td>           <td align="right" colspan="2" style="border-bottom: 1px solid black;">            8,065,594           </td>           <td style="border-bottom: 1px solid black;" width="1%">           </td>           <td width="2%">           </td>           <td align="right" colspan="2" style="border-bottom: 1px solid black;">            6,877,304           </td>           <td style="border-bottom: 1px solid black;">           </td>          </tr>          <tr>           <td colspan="8">           </td>          </tr>          <tr bgcolor="#ccdaef">           <td valign="top">            Cash and cash equivalents at end of year           </td>           <td style="border-bottom: 3px double black;" valign="top" width="1%">            $           </td>           <td align="right" style="border-bottom: 3px double black;" valign="top" width="11%">            10,427,340           </td>           <td style="border-bottom: 3px double black;" valign="top" width="1%">           </td>           <td valign="top" width="2%">           </td>           <td style="border-bottom: 3px double black;" valign="top" width="1%">            $           </td>           <td align="right" style="border-bottom: 3px double black;" valign="top" width="11%">            8,065,594           </td>           <td style="border-bottom: 3px double black;" valign="top">           </td>          </tr>          <tr>           <td colspan="8">           </td>          </tr>          <tr bgcolor="#ccdaef">           <td colspan="8">            Supplemental disclosures of cash flow information:           </td>          </tr>          <tr>           <td>            <div style="margin-left: 18pt;">             Cash paid during the year for income taxes            </div>           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            2,438,788           </td>           <td width="1%">           </td>           <td width="2%">           </td>           <td width="1%">            $           </td>           <td align="right" width="11%">            2,586,661           </td>           <td>           </td>          </tr>         </tbody>        </table>       </div>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         <br/>         <br/>         See accompanying notes.         <br/>         <br/>        </font>       </div>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-6        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <b>        <font style="font-size: 10pt; font-family: Times New Roman">         <a href="#TOC">          Tableof Contents         </a>         <br/>         <br/>        </font>        <div align="center">         <a name="notes">         </a>         <font style="font-size: 10pt; font-family: Arial;">          NVECORPORATION          <br/>          NOTES TO FINANCIAL STATEMENTS         </font>        </div>       </b>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 1.DESCRIPTION OF BUSINESS        </b>        <br/>        We develop and sell devices that use spintronics,a nanotechnology that relies on electron spin rather than electron charge to acquire,store, and transmit information. We operate in one reportable segment.        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES         <br/>         Cash and Cash Equivalents        </b>        <br/>        We consider all highly liquid investments with maturitiesof three months or less when purchased to be cash equivalents.        <br/>        <br/>        <b>         Fair Value of Financial Instruments        </b>        <br/>        The carrying amount of cash and cash equivalents,accounts receivable, and accounts payable approximates fair value because of theshort maturity of these instruments. Fair values of marketable securities arebased on quoted market prices.        <br/>        <br/>        <b>         Concentration of Risk and Financial Instruments        </b>        <br/>        Financial instruments potentially subject to significantconcentrations of credit risk consist principally of cash equivalents, marketablesecurities, and accounts receivable.        <br/>        <br/>        Cash and cash equivalents have been maintained infinancial institutions we believe have high credit quality, however these accountsare generally in excess of federally insured amounts.        <br/>        <br/>        We have invested our excess cash in corporate-backedand municipal-backed bonds and money market instruments. Our investment policyprescribes purchases of only high-grade securities, and limits the amount of creditexposure to any one issuer. The effects of the COVID-19 pandemic have degradedoutlooks for some of our securities’ issuers, which may increase the riskof default on one or more securities.        <br/>        <br/>        Our customers are throughout the world. We generallydo not require collateral from our customers, but we perform ongoing credit evaluationsof their financial condition. More information on accounts receivable is containedin the paragraph titled “Accounts Receivable and Allowance for Doubtful Accounts”of this note. The effects of the COVID-19 pandemic could increase our bad-debtrisk in the future.        <br/>        <br/>        Additionally, we are dependent on critical suppliersincluding our packaging vendors and suppliers of certain raw silicon and semiconductorwafers that are incorporated in our products. The effects of the COVID-19 pandemichave increased the risk of supply interruptions.        <br/>        <br/>        <b>         Accounts Receivable and Allowance for Doubtful Accounts        </b>        <br/>        We grant credit to customers in the normal courseof business and at times may require customers to prepay for an order prior toshipment. Accounts receivable are recorded net of an allowance for doubtful accounts.We make estimates of the uncollectibility of accounts receivable. We specificallyanalyze accounts receivable, historical bad debts, and customer creditworthinesswhen evaluating the adequacy of the allowance. We had no charges or provisionsto our allowance for doubtful accounts in fiscal 2021 or 2020.        <br/>        <br/>        <b>         Inventories        </b>        <br/>        Inventories are stated at the lower of cost or netrealizable value. Cost is determined by the first in, first out method. We recordinventory reserves when we determine certain inventory is unlikely to be soldbased on sales trends, turnover, competition, and other market factors.        <br/>        <br/>        <b>         Product Warranty        </b>        <br/>        In general we warranty our products to be free fromdefects in material and workmanship for one year.        <br/>        <br/>        <b>         Fixed Assets        </b>        <br/>        Fixed assets are stated at cost. Depreciation ofmachinery and equipment is recorded over the estimated useful lives of the assets,generally five years, using the straight-line method. Amortization of leaseholdimprovements is recorded using the straight-line method over the lesser of thelease term or five-year useful life. We record losses on long-lived assets usedin operations when indicators of impairment are present and the undiscounted cashflows estimated to be generated by those assets are less than the assets’carrying amount. We did not identify any indicators of impairment during fiscal2021 or 2020. Depreciation and amortization expense related to fixed assets was$308,511 for fiscal 2021 and $364,409 for fiscal 2020.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-7        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>        <i>         <b>          Revenue Recognition         </b>        </i>        <br/>        We recognize revenue when we satisfy performance obligationsby the transfer of control of products or services to our customers, in an amountthat reflects the consideration we expect to be entitled to in exchange for thoseproducts or services. Revenue is disaggregated into product sales and contractresearch and development to depict the nature, amount, timing of revenue recognitionand economic characteristics of our business, and is represented within the financialstatements.        <br/>        <br/>        We recognize revenue from product sales to customersand distributors when we satisfy our performance obligation, at a point in time,on product shipment or delivery to our customer or distributor as determinedby agreed on shipping terms. Shipping charges billed to customers are includedin product sales and the related shipping costs are included in cost of sales.Under certain limited circumstances, our distributors may earn commissions foractivities unrelated to their purchases of our products, such as for facilitatingthe sale of custom products or research and development contracts with third parties.We recognize any such commissions as selling, general, and administrative expenses.We recognize discounts provided to our distributors as reductions in revenue.        <br/>        <br/>        We recognize contract research and development revenueover a period of time as the performance obligation is satisfied over a periodof time rather than a point in time. Contracts have specifications unique to eachcustomer and do not create an asset with an alternate use, and we have an enforceableright to payment for performance completed to date. We recognize revenue overa period of time using costs incurred as the measurement of progress towards completion.        <br/>        <br/>        Accounts receivable is recognized when we have transferreda good or service to a customer and our right to receive consideration is unconditionalthrough the completion of our performance obligation. A contract asset is recognizedwhen we have a right to consideration from the transfer of goods or services toa customer but have not completed our performance obligation. A contract liabilityis recognized when we have been paid by a customer but have not yet satisfiedthe performance obligation by transferring goods or services. We had no materialcontract assets or contract liabilities as of March 31, 2021 or March 31,2020.        <br/>        <br/>        Our performance obligations related to product salesand contract research and development contracts are satisfied in one year or less.Unsatisfied performance obligations represent contracts with an original expectedduration of one year or less. As permitted under Accounting Standards Codification(“ASC”) Topic 606,        <i>         Revenue from Contracts with Customers        </i>        ,we are using the practical expedient not to disclose the value of these unsatisfiedperformance obligations. We also use the practical expedient in which we do notassess whether a contract has a significant financing component if the expectationat contract inception is such that the period between payment by the customerand the transfer of the promised goods or services to the customer will be oneyear or less.        <br/>        <br/>        <b>         Income Taxes        </b>        <br/>        We account for income taxes using the asset andliability method. Deferred income taxes are provided for temporary differencesbetween the financial reporting and tax bases of assets and liabilities. We providevaluation allowances against deferred tax assets if we determine that it is lesslikely than not that we will be able to utilize the deferred tax assets.        <br/>        <br/>        <b>         Research and Development Expense Recognition        </b>        <br/>        Research and development costs are expensed as theyare incurred. Customer-sponsored research and development costs are included incost of sales.        <br/>        <br/>        <b>         Stock-Based Compensation        </b>        <br/>        We measure stock-based compensation cost at thegrant date based on the fair value of the award and recognize the compensationexpense over the requisite service period, which is generally the vesting period.We recognize any forfeitures as they occur.        <br/>        <br/>        <b>         Net Income Per Share        </b>        <br/>        Net income per basic share is computed based onthe weighted-average number of common shares issued and outstanding during eachyear. Net income per diluted share amounts assume exercise of all stock options.The following table shows the components of diluted shares:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="75%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            YearEnded March 31           </b>          </td>         </tr>         <tr>          <td align="center" style="border-bottom: 1px solid black;" width="11%">           <b>            2021           </b>          </td>          <td width="3%">          </td>          <td align="center" style="border-bottom: 1px solid black;" width="11%">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Weighted average common shares outstanding – basic          </td>          <td align="right" width="16%">           4,834,054          </td>          <td align="right" colspan="2">           4,845,627          </td>         </tr>         <tr>          <td>           Dilutive effect of stock options          </td>          <td align="right" style="border-bottom: 1px solid black;">           408          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;">           1,667          </td>         </tr>         <tr bgcolor="#ccdaef" valign="top">          <td>           Shares used in computing net income per share – diluted          </td>          <td align="right" style="border-bottom: 3px double black;">           4,834,462          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;">           4,847,294          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <b>         Use of Estimates        </b>        <br/>        The preparation of financial statements in conformitywith U.S. generally accepted accounting principles requires us to make estimatesand assumptions that affect the amounts reported in the financial statements andaccompanying notes. Actual results could differ from those estimates.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-8        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a href="#TOC">          Tableof Contents         </a>        </b>        <br/>        <br/>        <b>         Recently Issued Accounting Standards        </b>        <br/>        <br/>        <i>         <b>          New Accounting Standards Not Yet Adopted         </b>        </i>        <br/>        In December 2019, the Financial Accounting StandardsBoard (“FASB”) issued Accounting Standards Update (“ASU”)No. 2019-12,        <i>         Income Taxes (Topic 740)—Simplifying the Accounting for IncomeTaxes        </i>        . ASU 2019-12 is intended to simplify accounting for income taxes.It removes certain exceptions to the general principles in Topic 740 and amendsexisting guidance to improve consistent application. ASU 2019-12 is effectivefor fiscal years beginning after December 15, 2020 and interim periods withinthose fiscal years, which is fiscal 2022 for us. We do not expect adoption ofthe new guidance to have a significant impact on our financial statements.        <br/>        <br/>        In June 2016, the FASB issued ASU No. 2016-13,        <i>         Financial Instruments—Credit Losses (Topic 326), Measurement of CreditLosses on Financial Statements        </i>        . ASU 2016-13 requires a financial asset(or a group of financial assets) measured at amortized cost basis to be presentedat the net amount expected to be collected. The allowance for credit losses isa valuation account that is deducted from the amortized cost basis of the financialasset(s) to present the net carrying value at the amount expected to be collectedon the financial asset. In November 2018 the FASB issued ASU No. 2018-19,        <i>         Codification Improvements to Topic 326, Financial Instruments—CreditLosses        </i>        , which clarifies codification and corrects unintended application ofthe guidance, and in November 2019, the FASB issued ASU No. 2019-11,        <i>         CodificationImprovements to Topic 326, Financial Instruments-Credit Losses        </i>        , which clarifiesor addresses specific issues about certain aspects of ASU 2016-13. In November 2019the FASB issued ASU No. 2019-10,        <i>         Financial Instruments—Credit Losses(Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842):Effective Dates        </i>        , and in February 2020 the FASB issued ASU No. 2020-02,        <i>         Financial Instruments—Credit Losses (Topic 326) and Leases (Topic842): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119and Update to SEC Section on Effective Date Related to Accounting Standards UpdateNo. 2016-02, Leases (Topic 842)        </i>        , both of which delay the effectivedate of ASU 2016-13 by three years for certain Smaller Reporting Companiessuch as us. In March 2020, the FASB issued ASU No. 2020-03,        <i>         CodificationImprovements to Financial Instruments        </i>        ; which modifies the measurement of expectedcredit losses of certain financial instruments. In accordance with ASU 2019-10and ASU 2020-02, ASU 2016-13 is effective for certain Smaller ReportingCompanies for financial statements issued for fiscal years beginning after December 15,2022 and interim periods within those fiscal years, which will be fiscal 2024for us if we continue to be classified as a Smaller Reporting Company, with earlyadoption permitted. We do not expect adoption of the new guidance to have a significantimpact on our financial statements.        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 3. FAIR VALUE OF FINANCIAL INSTRUMENTS        </b>        <br/>        Our corporate bonds and money market funds areclassified as available-for-sale securities and carried at estimated fair value.Unrealized holding gains and losses are included in accumulated other comprehensiveincome in the statement of shareholders’ equity. Corporate bonds with remainingmaturities less than one year are classified as short-term, and those with remainingmaturities greater than one year are classified as long-term. We consider allhighly-liquid investments with maturities of three months or less when purchased,including money market funds, to be cash equivalents. Gains and losses on marketablesecurity transactions are reported on the specific-identification method.        <br/>        <br/>        The fair value of our available-for-sale securities asof March 31, 2021 by maturity were as follows:        <br/>        <br/>       </font>       <table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="50%">        <tbody>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Total           </b>          </td>          <td width="4%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            &lt;1Year           </b>          </td>          <td width="4%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            1–3Years           </b>          </td>          <td width="4%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            3–5Years           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td width="1%">           $          </td>          <td align="right" width="12%">           64,860,822          </td>          <td>          </td>          <td width="1%">           $          </td>          <td align="right" width="12%">           17,822,153          </td>          <td>          </td>          <td width="1%">           $          </td>          <td align="right" width="12%">           36,716,130          </td>          <td width="2%">          </td>          <td width="1%">           $          </td>          <td align="right" width="12%">           10,322,539          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        Total available-for-sale securities representedapproximately 89% of our total assets. Marketable securities as of March 31,2021 had remaining maturities between 20 weeks and 47 months.        <br/>        <br/>        Generally accepted accounting principles establisha framework for measuring fair value, provide a definition of fair value, andprescribe required disclosures about fair-value measurements. Generally acceptedaccounting principles define fair value as the price that would be received tosell an asset or paid to transfer a liability. Fair value is a market-based measurementthat should be determined using assumptions that market participants would usein pricing an asset or liability. Generally accepted accounting principles utilizea valuation hierarchy for disclosure of fair value measurements. The categorizationwithin the valuation hierarchy is based on the lowest level of input that is significantto the fair value measurement. The categories within the valuation hierarchy aredescribed as follows:        <br/>        <br/>        Level 1 – Financial instruments with quotedprices in active markets for identical assets or liabilities.        <br/>        <br/>        Level 2 – Financial instruments with quotedprices in active markets for similar assets or liabilities. Level 2 fairvalue measurements are determined using either prices for similar instrumentsor inputs that are either directly or indirectly observable, such as interestrates.        <br/>        <br/>        Level 3 – Inputs to the fair value measurementare unobservable inputs or valuation techniques.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-9        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a href="#TOC">          Tableof Contents         </a>        </b>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <br/>        Money market funds are included on the balance sheetsin “Cash and cash equivalents.” Corporate bonds are included on thebalance sheets in “Marketable securities, short term” and “Marketablesecurities, long term.”        <br/>        <br/>        The following table shows the estimated fair valueof assets that were accounted for at fair value on a recurring basis:        <br/>        <br/>       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="8" style="border-bottom: 1px solid black;">           <b>            As ofMarch 31, 2021           </b>          </td>          <td rowspan="2" width="1">          </td>          <td align="center" colspan="8" style="border-bottom: 1px solid black;">           <b>            As ofMarch 31, 2020           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Level1           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Level2           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Total           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Level1           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Level2           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Total           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="bottom">           Money market funds          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           10,143,196          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           10,143,196          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           7,903,433          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           7,903,433          </td>         </tr>         <tr>          <td valign="bottom">           Corporate bonds          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           -          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           54,717,626          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           54,717,626          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           -          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           62,691,309          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           62,691,309          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           Total          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           10,143,196          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           54,717,626          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           64,860,822          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           7,903,433          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           62,691,309          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           70,594,742          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        Our available-for-sale securities as of March 31,2021 and 2020, aggregated into classes of securities, were as follows:        <br/>        <br/>       </font>       <table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="12" style="border-bottom: 1px solid black;">           <b>            Asof March 31, 2021           </b>          </td>          <td rowspan="2" width="1">          </td>          <td align="center" colspan="12" style="border-bottom: 1px solid black;">           <b>            Asof March 31, 2020           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            <br/>            Amortized            <br/>            Cost           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Gains           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Losses           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Estimated            <br/>            Fair            <br/>            Value           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            <br/>            Amortized            <br/>            Cost           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Gains           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Losses           </b>          </td>          <td width="1">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Estimated            <br/>            Fair            <br/>            Value           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="bottom">           Money market           <br/>           funds          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           10,143,196          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           10,143,196          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           7,903,433          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           -          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="bottom" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" valign="bottom">           7,903,433          </td>         </tr>         <tr>          <td valign="bottom">           Corporate bonds          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           53,308,105          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           1,570,195          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           (160,674          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           54,717,626          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           62,030,120          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           752,621          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           (91,432          </td>          <td style="border-bottom: 1px solid black;" valign="bottom">           )          </td>          <td>          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" valign="bottom">           62,691,309          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           Total          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           63,451,301          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           1,570,195          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           (160,674          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           )          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           64,860,822          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           69,933,553          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           752,621          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           (91,432          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           )          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           70,594,742          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        Thefollowing table shows the gross unrealized holding losses and fair value of ouravailable-for-sale securities with unrealized holding losses, aggregated by classof securities and length of time that individual securities had been in a continuousunrealized loss position as of March 31, 2021 and 2020.        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td colspan="2" rowspan="2">          </td>          <td align="center" colspan="6" style="border-bottom: 1px solid black;">           <b>            LessThan 12 Months           </b>          </td>          <td rowspan="2">          </td>          <td align="center" colspan="6" style="border-bottom: 1px solid black;">           <b>            12 Monthsor Greater           </b>          </td>          <td rowspan="2">          </td>          <td align="center" colspan="6" style="border-bottom: 1px solid black;">           <b>            Total           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Estimated            <br/>            Fair            <br/>            Value           </b>          </td>          <td>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Losses           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Estimated            <br/>            Fair            <br/>            Value           </b>          </td>          <td>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Losses           </b>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Estimated            <br/>            Fair            <br/>            Value           </b>          </td>          <td>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Gross            <br/>            Unrealized            <br/>            Holding Losses           </b>          </td>         </tr>         <tr>          <td colspan="22">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="22">           As of March 31, 2021          </td>         </tr>         <tr>          <td>          </td>          <td>           Corporate bonds          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           10,322,539          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="8%">           (160,674          </td>          <td style="border-bottom: 1px solid black;" width="1%">           )          </td>          <td width="4%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           -          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td style="border-bottom: 1px solid black;" width="9%">          </td>          <td align="right" style="border-bottom: 1px solid black;" width="1%">           -          </td>          <td width="4%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           10,322,539          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="8%">           (160,674          </td>          <td style="border-bottom: 1px solid black;" width="1%">           )          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="top">           Total          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           10,322,539          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="8%">           (160,674          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           )          </td>          <td bgcolor="#ccdaef" width="4%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           -          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           -          </td>          <td bgcolor="#ccdaef" width="4%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           10,322,539          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="8%">           (160,674          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           )          </td>         </tr>         <tr>          <td colspan="22">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="22">           As of March 31, 2020          </td>         </tr>         <tr>          <td>          </td>          <td>           Corporate bonds          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           19,525,169          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="8%">           (91,432          </td>          <td style="border-bottom: 1px solid black;" width="1%">           )          </td>          <td width="4%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           -          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;" width="1%">           $          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;">           -          </td>          <td width="4%">          </td>          <td style="border-bottom: 1px solid black;">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="9%">           19,525,169          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;">           $          </td>          <td align="right" style="border-bottom: 1px solid black;" width="8%">           (91,432          </td>          <td style="border-bottom: 1px solid black;" width="1%">           )          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" valign="top">           Total          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           19,525,169          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="8%">           (91,432          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           )          </td>          <td bgcolor="#ccdaef" width="4%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           -          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           $          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;">           -          </td>          <td bgcolor="#ccdaef" width="4%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="9%">           19,525,169          </td>          <td bgcolor="#ccdaef" width="2%">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="8%">           (91,432          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">           )          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        We did not consider any of our available-for-salesecurities to be impaired as of March 31, 2021. None of the securities wereimpaired at acquisition, and subsequent declines in fair value are not attributedto declines in credit quality. The effects of the COVID-19 pandemic, however,have degraded outlooks for some of our marketable securities’ issuers, whichcould lead to credit-quality downgrades in the future. When evaluating for impairmentwe assess indicators that include, but are not limited to, earnings performance,changes in underlying credit ratings, market conditions, bona fide offers to purchaseor sell, and ability to hold until maturity. Because we believe it is more likelythan not we will recover the cost basis of our investments, we did not considerany of our marketable securities to be impaired as of March 31, 2021.        <br/>        <b>         <br/>         NOTE 4. INVENTORIES        </b>        <br/>        Inventories are shown in the following table:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="50%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="5" style="border-bottom: 1px solid black;">           <b>            March31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Raw materials          </td>          <td width="1%">           $          </td>          <td align="right" width="22%">           660,678          </td>          <td width="4%">          </td>          <td width="1%">           $          </td>          <td align="right" width="22%">           1,017,451          </td>         </tr>         <tr>          <td>           Work in process          </td>          <td>          </td>          <td align="right">           2,220,723          </td>          <td>          </td>          <td>          </td>          <td align="right">           1,863,000          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Finished goods          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           1,019,376          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           1,003,999          </td>         </tr>         <tr valign="top">          <td>           Total inventories          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           3,900,777          </td>          <td>          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           3,884,450          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-10        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <a href="#TOC">          Tableof Contents         </a>        </b>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 5.STOCK-BASED COMPENSATION         <br/>         Stock Option Plan        </b>        <br/>        Our 2000 Stock Option Plan, as amended, providesfor issuance to employees, directors, and certain service providers of incentivestock options and nonstatutory stock options. Generally, the options may be exercisedat any time prior to expiration, subject to vesting based on terms of employment.The period ranges from immediate vesting to vesting over a five-year period. Theoptions have exercisable lives ranging from one year to ten years from the dateof grant, and are generally not eligible to vest early in the event of retirement,death, disability, or change in control. Exercise prices are not less than fairmarket value of the underlying Common Stock at the date the options are granted.Stock-based compensation expense was $45,572 in fiscal 2021 and $48,360 in fiscal2020.        <br/>        <br/>        <b>         Valuation assumptions        </b>        <br/>        We use the Black-Scholes standard option-pricingmodel to determine the fair value of stock options. The following assumptionswere used to estimate the fair value of options granted:        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="45%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="5" style="border-bottom: 1px solid black;">           <b>            Year Ended March 31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td width="6%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Risk-free interest rate          </td>          <td align="right" width="10%">           0.2 – 0.4          </td>          <td width="1%">           %          </td>          <td>          </td>          <td align="right" width="10%">           1.7          </td>          <td width="1%">           %          </td>         </tr>         <tr>          <td>           Expected volatility          </td>          <td align="right">           34 – 35          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           37          </td>          <td>           %          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Expected life (years)          </td>          <td align="right">           4.6          </td>          <td>          </td>          <td>          </td>          <td align="right">           4.6          </td>          <td>          </td>         </tr>         <tr>          <td>           Dividend yield          </td>          <td align="right">           7.0 – 7.4          </td>          <td>           %          </td>          <td>          </td>          <td align="right">           5.9          </td>          <td>           %          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        The determination of the fair value of the awardson the date of grant using the Black-Scholes model is affected by our stock priceas well as assumptions of other variables, including projected stock option exercisebehaviors, risk-free interest rate, and expected volatility of our stock pricein future periods. Our estimates and assumptions affect the amounts reported inthe financial statements and accompanying notes.        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <i>          <br/>          Expected life         </i>        </b>        <br/>        We analyze historical exercise and termination datato estimate the expected life assumption. We believe historical data currentlyrepresents the best estimate of the expected life of a new option.        <br/>        <br/>        <b>         <i>          Risk-free interest rate         </i>        </b>        <br/>        The risk-free rate is based on the yield of U.S.Treasury securities on the grant date for maturities similar to the expected livesof the options.        <br/>        <br/>        <b>         <i>          Volatility         </i>        </b>        <br/>        We use historical volatility to estimate the expectedvolatility of our common stock.        <br/>        <br/>        <b>         <i>          Dividend yield         </i>        </b>        <br/>        We assumed a 7.0% to 7.4% dividend yield for fiscal2021 and 5.9% for fiscal 2020 based on the dividend yield on the date the optionswere granted.        <br/>        <br/>        <b>         Tax effects of stock-based compensation        </b>        <br/>        Stock-based compensation increased deferred taxassets by $9,971 for fiscal 2021 and $10,581 for fiscal 2020.        <br/>        <br/>        <b>         General stock option information        </b>        <br/>        The following table summarizes information on optionsoutstanding as of March 31, 2021:        <br/>        <br/>       </font>       <table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td align="center" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Rangesof            <br/>            Exercise Prices           </b>          </td>          <td width="4%">          </td>          <td align="center" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Number            <br/>            Outstanding           </b>          </td>          <td width="4%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Weighted Average            <br/>            Exercise Price           </b>          </td>          <td width="4%">          </td>          <td align="center" style="border-bottom: 1px solid black;" valign="bottom">           <b>            Weighted Remaining            <br/>            Contractual Life (years)           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td align="right">           $49.86 – $67.69          </td>          <td>          </td>          <td align="right">           22,000          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           59.85          </td>          <td>          </td>          <td align="right">           5.3          </td>         </tr>         <tr>          <td align="right">           $76.13 – $107.86          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;">           8,000          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           92.00          </td>          <td>          </td>          <td align="right" style="border-bottom: 1px solid black;">           6.9          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           30,500          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           68.28          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           5.7          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         <i>         </i>        </b>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        Asummary of our stock options is shown in the following table:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td>          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Option Shares            <br/>            Reserved           </b>          </td>          <td width="3%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            Options            <br/>            Outstanding           </b>          </td>          <td width="3%">          </td>          <td align="center" colspan="2" style="border-bottom: 1px solid black;">           <b>            WeightedAverage            <br/>            Option Exercise Price           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" valign="top">           At March 31, 2019          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           135,230          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           22,000          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" width="1%">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top" width="1%">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 3px double black;" valign="top">           70.89          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Granted           </div>          </td>          <td align="right">           (4,000          </td>          <td>           )          </td>          <td>          </td>          <td align="right">           4,000          </td>          <td>          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           67.65          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Exercised           </div>          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           -          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           (2,000          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           )          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           56.18          </td>         </tr>         <tr>          <td valign="top">           At March 31, 2020          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           131,230          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           24,000          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           71.58          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           <div style="margin-left: 9pt;">            Granted           </div>          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           (6,500          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           )          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           6,500          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           $          </td>          <td align="right" bgcolor="#ccdaef" style="border-bottom: 1px solid black;">           56.12          </td>         </tr>         <tr>          <td valign="top">           At March 31, 2021          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           124,730          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           30,500          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           68.28          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-11        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        The remaining weighted-average exercisable lifewas 5.7 years as of March 31, 2021 and 6.6 years as of March 31,2020. 28,000 outstanding options were exercisable as of March 31, 2021 and24,000 outstanding options were exercisable as of March 31, 2020. The total intrinsicvalue of options outstanding March 31, 2021, based on our closing stock pricefor that day, was $230,540, $191,140 of which was exercisable. The total fairvalue of option grants was $47,140 in fiscal 2021. There was $1,568 of unrecognizedstock-based compensation as of March 31, 2021 related to nonvested options, whichwe expect to recognize in the first quarter of fiscal 2022.        <br/>        <br/>        <b>         NOTE 6. INCOME TAXES        </b>        <br/>        Income tax provisions for fiscal 2021 and 2020 consistedof the following:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="7" style="border-bottom: 1px solid black;">           <b>            YearEnded March 31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td width="3%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="8">           Current taxes          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            Federal           </div>          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           2,600,670          </td>          <td width="1%">          </td>          <td width="3%">          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           2,710,658          </td>          <td width="1%">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            State           </div>          </td>          <td align="right" colspan="2">           75,852          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           (13,176          </td>          <td>           )          </td>         </tr>         <tr>          <td colspan="8">           Deferred taxes          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           <div style="margin-left: 9pt;">            Federal           </div>          </td>          <td align="right" colspan="2">           (123,959          </td>          <td>           )          </td>          <td>          </td>          <td align="right" colspan="2">           74,651          </td>          <td>          </td>         </tr>         <tr>          <td>           <div style="margin-left: 9pt;">            State           </div>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           (5,195          </td>          <td style="border-bottom: 1px solid black;">           )          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           3,128          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef" valign="top">          <td>           Income tax provision          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           2,547,368          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;">           2,775,261          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        Areconciliation of income tax provisions at the U.S. statutory rate for fiscal2021 and 2020 is as follows:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td rowspan="2" width="57%">          </td>          <td align="center" colspan="7" style="border-bottom: 1px solid black;">           <b>            YearEnded March 31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td width="3%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Tax expense at U.S. Statutory rate          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           2,990,768          </td>          <td width="1%">          </td>          <td width="2%">          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           3,633,400          </td>          <td width="1%">          </td>         </tr>         <tr>          <td>           State income taxes, net of Federal benefit          </td>          <td>          </td>          <td align="right" width="15%">           88,909          </td>          <td>          </td>          <td width="2%">          </td>          <td>          </td>          <td align="right" width="15%">           77,989          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Research and development credits          </td>          <td>          </td>          <td align="right" width="15%">           (86,223          </td>          <td>           )          </td>          <td width="2%">          </td>          <td>          </td>          <td align="right" width="15%">           (126,320          </td>          <td>           )          </td>         </tr>         <tr>          <td>           Foreign-derived intangible income deduction          </td>          <td>          </td>          <td align="right" width="15%">           (450,912          </td>          <td>           )          </td>          <td width="2%">          </td>          <td>          </td>          <td align="right" width="15%">           (540,265          </td>          <td>           )          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Other          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" width="15%">           4,826          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td width="2%">          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td align="right" style="border-bottom: 1px solid black;" width="15%">           (269,543          </td>          <td style="border-bottom: 1px solid black;">           )          </td>         </tr>         <tr valign="top">          <td>           Income tax provision          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;" width="15%">           2,547,368          </td>          <td style="border-bottom: 3px double black;">          </td>          <td width="2%">          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;" width="15%">           2,775,261          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        Deferred income taxes reflect the net tax effectsof temporary differences between the carrying amount of assets and liabilitiesfor financial reporting purposes and the amounts used for income tax purposes.Significant components of our deferred tax assets and liabilities as of March 31,2021 and 2020 were as follows:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td rowspan="2" width="59%">          </td>          <td align="center" colspan="7" style="border-bottom: 1px solid black;">           <b>            March31           </b>          </td>         </tr>         <tr>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td width="3%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Paid time off accrual          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           60,869          </td>          <td width="1%">          </td>          <td>          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           55,240          </td>          <td width="1%">          </td>         </tr>         <tr>          <td>           Inventory reserve          </td>          <td align="right" colspan="2">           50,324          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           45,948          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Depreciation and amortization          </td>          <td align="right" colspan="2">           88,690          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           22,651          </td>          <td>          </td>         </tr>         <tr>          <td>           Stock-based compensation deductions          </td>          <td align="right" colspan="2">           75,189          </td>          <td>          </td>          <td>          </td>          <td align="right" colspan="2">           65,218          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Unrealized gain on marketable securities          </td>          <td align="right" colspan="2">           (308,403          </td>          <td>           )          </td>          <td>          </td>          <td align="right" colspan="2">           (144,668          </td>          <td>           )          </td>         </tr>         <tr>          <td>           Other          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           106,869          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           63,730          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Deferred tax assets          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;" width="16%">           73,538          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;">           $          </td>          <td align="right" style="border-bottom: 3px double black;" width="16%">           108,119          </td>          <td style="border-bottom: 3px double black;">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        We had no unrecognized tax benefits as of March 31,2021, and we do not expect any significant unrecognized tax benefits within 12 monthsof the reporting date. We recognize interest and penalties related to income taxmatters in income tax expense. As of March 31, 2021 we had no accrued interestrelated to uncertain tax positions. The tax years 2016 through 2019 remain opento examination by the major taxing jurisdictions to which we are subject.        <br/>        <br/>        <b>         NOTE 7. LEASES        </b>        <br/>        We conduct our operations in a leased facility undera non-cancellable lease expiring March 31, 2026. Our lease does not provide animplicit rate, so we used our incremental borrowing rate to determine the presentvalue of lease payments. Lease expense is recognized on a straight-line basisover the lease term. Variable lease costs consist primarily of common area maintenanceand real estate taxes which are paid based on actual costs incurred by the lessor.Details of our operating lease are as follows:        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-12        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td colspan="2">          </td>          <td align="center" colspan="7" style="border-bottom: 1px solid black;">           <b>            Year Ended March 31           </b>          </td>         </tr>         <tr>          <td colspan="2">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2021           </b>          </td>          <td align="center" width="3%">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            2020           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td colspan="2">           Operating lease cost          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           158,439          </td>          <td width="1%">          </td>          <td>          </td>          <td width="1%">           $          </td>          <td align="right" width="16%">           154,565          </td>          <td width="1%">          </td>         </tr>         <tr>          <td colspan="2">           Variable lease cost          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           109,449          </td>          <td style="border-bottom: 1px solid black;">          </td>          <td>          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           96,798          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td colspan="2">           Total          </td>          <td style="border-bottom: 3px double black;" valign="top" width="1%">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top" width="10%">           267,888          </td>          <td style="border-bottom: 3px double black;">          </td>          <td>          </td>          <td style="border-bottom: 3px double black;" valign="top">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top">           251,363          </td>          <td style="border-bottom: 3px double black;" valign="top">          </td>         </tr>         <tr>          <td colspan="9">          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="9">           Cash paid for amounts included in the measurementof lease liabilities          </td>         </tr>         <tr>          <td colspan="2">           <div style="margin-left: 9pt;">            Operating cash flows for leases           </div>          </td>          <td width="1%">           $          </td>          <td align="right">           133,299          </td>          <td>          </td>          <td>          </td>          <td>           $          </td>          <td align="right">           174,528          </td>          <td>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" colspan="3">           Remaining lease term          </td>          <td align="right" bgcolor="#ccdaef">           5 years          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td bgcolor="#ccdaef">          </td>          <td align="right" bgcolor="#ccdaef">           6 years          </td>          <td bgcolor="#ccdaef">          </td>         </tr>         <tr>          <td colspan="3">           Discount rate          </td>          <td align="right" valign="top" width="10%">           3.5          </td>          <td>           %          </td>          <td>          </td>          <td>          </td>          <td align="right" valign="top">           3.5          </td>          <td>           %          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        The following table presents the maturitiesof lease liabilities as of March 31, 2021:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="67%">        <tbody>         <tr>          <td style="border-bottom: 1px solid black;">           <b>            Year Ending March 31           </b>          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            Operating Leases           </b>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           2022          </td>          <td align="right" colspan="2">           152,703          </td>          <td width="1%">          </td>         </tr>         <tr>          <td>           2023          </td>          <td align="right" colspan="2">           156,121          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           2024          </td>          <td align="right" colspan="2">           159,592          </td>          <td>          </td>         </tr>         <tr>          <td>           2025          </td>          <td align="right" colspan="2">           163,224          </td>          <td>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           2026          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           165,947          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr>          <td>           Total lease payments          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           797,587          </td>          <td style="border-bottom: 1px solid black;">          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Imputed lease interest          </td>          <td align="right" colspan="2" style="border-bottom: 1px solid black;">           (65,855          </td>          <td style="border-bottom: 1px solid black;">           )          </td>         </tr>         <tr>          <td valign="top">           Total lease liabilities          </td>          <td style="border-bottom: 3px double black;" valign="top" width="1%">           $          </td>          <td align="right" style="border-bottom: 3px double black;" valign="top" width="10%">           731,732          </td>          <td style="border-bottom: 3px double black;" width="1%">          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <b>         NOTE 8. CONCENTRATIONS        </b>        <br/>        The following table summarizes customers comprising10% or more of revenue for the two most recent fiscal years:        <br/>        <br/>       </font>       <table align="center" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="44%">        <tbody>         <tr>          <td rowspan="2">          </td>          <td align="center" colspan="3" style="border-bottom: 1px solid black;">           <b>            <font style="white-space: nowrap;">             %of Revenue for             <br/>             Year Ended March 31            </font>           </b>          </td>         </tr>         <tr>          <td align="center" style="border-bottom: 1px solid black;" width="16%">           <b>            2021           </b>          </td>          <td width="6%">          </td>          <td align="center" style="border-bottom: 1px solid black;" width="16%">           <b>            2020           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef">           Customer A          </td>          <td align="center" bgcolor="#ccdaef">           22%          </td>          <td bgcolor="#ccdaef">          </td>          <td align="center" bgcolor="#ccdaef">           24%          </td>         </tr>         <tr>          <td>           Customer B          </td>          <td align="center">           15%          </td>          <td>          </td>          <td align="center">           14%          </td>         </tr>         <tr bgcolor="#ccdaef">          <td>           Customer C          </td>          <td align="center">           Less than 10%          </td>          <td>          </td>          <td align="center">           10%          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        These customers accounted for 43% of ouraccounts receivable as of March 31, 2021 and 43% as ofMarch 31, 2020. We believe the receivable balances from these customers donot represent a significant credit risk based on past collection experience.        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 9.STOCK REPURCHASE PROGRAM        </b>        <br/>        On January 21, 2009 we announced thatour Board of Directors authorized the repurchase of up to $2,500,000 of our CommonStock from time to time in open market, block, or privately negotiated transactions.The timing and extent of any repurchases depends on market conditions, the tradingprice of the company’s stock, and other factors, and subject to the restrictionsrelating to volume, price, and timing under applicable law. On August 27,2015, we announced that our Board of Directors authorized up to $5,000,000 ofadditional repurchases. Our repurchase program does not have an expiration dateand does not obligate us to purchase any shares. The Program may be modified ordiscontinued at any time without notice. We intend to finance any stock repurchaseswith cash provided by operating activities or maturating marketable securities.We repurchased 1,806 shares of our Common Stock in fiscal 2021and 12,972 shares in fiscal 2020.The remaining authorization was $3,762,040 as of March 31, 2021.The Stock Repurchase Program may be modified ordiscontinued at any time without notice.        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 10.INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS        </b>        <br/>        All of our employees are eligible to participatein our 401(k) savings plan the first quarter after reaching age 21. Employeesmay contribute up to the Internal Revenue Code maximum. We make matching contributionsof 100% of the first 3% of participants’ salary deferral contributions. Ourmatching contributions were $94,498 for fiscal 2021 and $92,880 for fiscal2020.        <br/>        <br/>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <b>         NOTE 11.SUBSEQUENT EVENTS        </b>        <br/>        On May 5, 2021 we announced that our Board had declareda quarterly cash dividend of $1.00 per share of Common Stock to be paid May 31,2021 to shareholders of record as of the close of business May 17, 2021.        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-13        </font>       </div>       <hr/>       <div style="page-break-after: always;">       </div>       <font style="font-size: 10pt; font-family: Times New Roman">        <a href="#TOC">         <b>          Tableof Contents         </b>        </a>       </font>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: 'Arial','Helvetica';">         <b>          EXHIBIT INDEX         </b>         <br/>        </font>       </div>       <table align="center" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times New Roman" width="100%">        <tbody>         <tr>          <td style="border-bottom: 1px solid black;">           <b>            Exhibit #           </b>          </td>          <td align="center" style="border-bottom: 1px solid black;">           <b>            Description           </b>          </td>         </tr>         <tr>          <td bgcolor="#ccdaef" style="width: 27pt;" valign="top">           4          </td>          <td bgcolor="#ccdaef">           <a href="ex4.htm">            Description of the registrant’s securitiesregistered pursuant to Section 12 of the Securities Exchange Act of 1934.           </a>          </td>         </tr>         <tr>          <td valign="top">           10.18          </td>          <td>           <a href="stj-a7.htm">            Amendment No. 7 to Supplier Partnering Agreement betweenAbbott and the company.           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td style="width: 27pt;" valign="top">           23          </td>          <td>           <a href="ex23.htm">            Consent of Boulay PLLP.           </a>          </td>         </tr>         <tr>          <td valign="top">           31.1          </td>          <td>           <a href="ex31-dab.htm">            Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           31.2          </td>          <td valign="top">           <a href="ex31-car.htm">            Certification by Curt A. Reynders pursuant to Rule 13a-14(a)/15d-14(a).           </a>          </td>         </tr>         <tr>          <td valign="top">           32          </td>          <td valign="top">           <a href="ex32.htm">            Certification by Daniel A. Baker and Curt A. Reynders pursuant to 18 U.S.C. Section 1350.           </a>          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.INS          </td>          <td>           XBRL Instance Document          </td>         </tr>         <tr>          <td valign="top">           101.SCH          </td>          <td>           XBRL Taxonomy Extension Schema Document          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.CAL          </td>          <td>           XBRL Taxonomy Extension Calculation Linkbase Document          </td>         </tr>         <tr>          <td valign="top">           101.DEF          </td>          <td>           XBRL Taxonomy Extension Definition Linkbase Document          </td>         </tr>         <tr bgcolor="#ccdaef">          <td valign="top">           101.LAB          </td>          <td>           XBRL Taxonomy Extension Label Linkbase Document          </td>         </tr>         <tr>          <td valign="top">           101.PRE          </td>          <td>           XBRL Taxonomy Extension Presentation Linkbase Document          </td>         </tr>        </tbody>       </table>       <font style="font-size: 10pt; font-family: Times New Roman">        <br/>        <br/>        <br/>        <br/>       </font>       <div align="center">        <font style="font-size: 10pt; font-family: Times New Roman">         F-14        </font>       </div>       <hr/>      </text>     </description>    </filename>   </sequence>  </type> </document></body>